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SIGNALING MECHANISMS REGULATING NEURONAL
GROWTH CONE DYNAMICS

by

KARINE TORNIERI

Under the Direction of Dr. Vincent Rehder

ABSTRACT

During the development of the nervous system, neurons migrate to their final location
and extend neurites that navigate long distances in the extracellular environment to reach their
synaptic targets. The proper functioning of the nervous system depends on correct connectivity,
and mistakes in the wiring of the nervous system lead to brain abnormalities and mental illness.
Growth cones are motile structures located at the tip of extending neurites that sense and respond
to guidance cues encountered along the path toward their targets. Binding of these cues to
receptors located on growth cone filopodia and lamellipodia triggers intracellular signaling
pathways that regulate growth cone cytoskeletal dynamics. Although studies on extracellular
cues and their effects on neuronal guidance are well documented, less is known about the
intracellular signaling mechanisms that regulate growth cone motility. This dissertation focuses
on two signaling pathways and describes how they might be involved in determining growth
cone morphology during neuronal development. The specific aims of this work address: (1) the

role of phosphatidylinositol-3-kinase (PI-3K) and its downstream signaling pathway in
regulating growth cone motility, and (2) the effect of nitric oxide (NO) release from a single cell
on growth cone morphology of neighboring neurons.
This study employs defined neurons from the pond snail, Helisoma trivolvis, to
demonstrate that inhibition of PI-3K induces a concomitant increase in filopodial length and a
decrease in the rate at which neurites advance. These effects are mediated through the lipid and
protein kinase activities of PI-3K, and filopodial elongation is due to an increase in the rate at
which filopodia elongate and the time that individual filopodia spend extending. Additionally,
this study demonstrates that NO release from a single cell can affect growth cone dynamics on
neighboring neurons via soluble guanylyl cyclase (sGC), and that NO has a physiological effect
up to a distance of 100 µm. Overall this study provides new information on cellular mechanisms
regulating growth cone motility, and suggests a potential role of PI-3K and NO in neuronal
pathfinding in vivo.
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Chapter 1 : General Introduction
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Specific Aims of Dissertation
Growth cones located at the tip of newly extended neurites are critical motile and sensory
structures that are necessary for correct neuronal guidance during the development and
regeneration of the nervous system. Filopodia, composed of bundles of F-actin, are the first sites
of contact with guidance cues, and contact of a single filopodium is enough to reorient the
growth cone toward or away from the contact point. The actin-based motility of growth cone
filopodia is integral to correct guidance and subsequent connectivity. Therefore a better
understanding of molecules and second messengers that regulate filopodial dynamics is crucial to
prevent neuronal misguidance during the development or regeneration of the nervous system.
The objective of this study is to determine the cellular mechanisms and second messengers
involved in the regulation of growth cone dynamics. This dissertation employs Helisoma
trivolvis as a model system to investigate: (i) the role of PI-3K and its downstream targets in
regulating growth cone dynamics, and (ii) the effect of physiological concentrations of the
gaseous messenger NO on growth cone morphology.

Specific Aim 1 (Chapter 2): Does PI-3K and its downstream targets regulate filopodial
dynamics?
PI-3K has been demonstrated to regulate neurite outgrowth and to be expressed in growth cones
(Rodgers and Theibert, 2002). These data suggest that PI-3K can regulate growth cone guidance,
but does not provide information about the pathway through which PI-3K exerts its effect, or its
role in the regulation of growth cone morphology. Therefore the present study tests the
hypothesis that PI-3K affects filopodial dynamics and neurite outgrowth. Furthermore, this study
hypothesizes that these effects are mediated through the lipid and protein kinase activities of PI-
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3K, and subsequently via Akt, Rho kinase (ROCK) and MEKK, ultimately affecting the
dynamics of the actin cytoskeleton.

Specific Aim 2 (Chapter 3): Determine whether NO release from a physiological source
affects growth cone motility and examine the underlying signaling pathway.
Global and local applications of NO via NO donors on Helisoma B5 neurons induce an increase
in filopodial length, a decrease in filopodial number and an increase in [Ca2+]i (Van Wagenen
and Rehder, 1999; Van Wagenen and Rehder, 2001; Welshhans and Rehder, 2005; Welshhans
and Rehder, 2007). Local application of NO exerts its effect on growth cone morphology and
calcium concentration via a signaling pathway involving sGC, cyclic guanosine monophosphate
(cGMP), protein kinase G (PKG), and cyclic adenosine diphosphate ribose (cADPR) (Welshhans
and Rehder, 2005; Welshhans and Rehder, 2007). These data suggest that NO can regulate
growth cone dynamics during neuronal pathfinding. However the effect of NO release from a
physiological source on growth cone morphology has never been investigated. The present study
tests the hypothesis that NO which is spontaneously released from a single cell can affect growth
cone dynamics of neighboring neurons in a paracrine fashion. Such a demonstration would
provide evidence for NO acting as a paracrine messenger with the potential to affect the outcome
of neuronal pathfinding.

Overall, this dissertation investigates cellular mechanisms that control growth cone
morphology during neuronal pathfinding. Identification of molecules and second messengers that
affect growth cone dynamics has implications for clinical strategies to enhance correct
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navigation and appropriate connectivity during development of the nervous system, and also
during regeneration after injury.
The complex wiring and rewiring of the nervous system during development and
regeneration following injury require newly extended neurites to navigate long distances in order
to reach their targets and form synapses. This neuronal pathfinding depends on a sensory and
dynamic structure located at the tip of extending neurites, called the growth cone, on which
spatially and temporally regulated extracellular cues bind to receptors and trigger intracellular
signaling cascades that regulate cytoskeletal dynamics (Huber et al., 2003; Gallo and
Letourneau, 2004). Many of these guidance cues and their receptors have now been identified;
the guidance cues have been classified into two main categories by their action on growth cones,
attractive or repulsive (Goodman, 1996; Tessier-Lavigne and Goodman, 1996; Huber et al.,
2003). In each category these cues can have an effect over a short distance (contact-dependent
attraction or repulsion) or over a long distance (chemoattraction or chemorepulsion) (Goodman,
1996; Tessier-Lavigne and Goodman, 1996; Huber et al., 2003). However, it has recently been
shown that many individual cues can be both attractive and repulsive, depending (i) on the state
of the growth cone, (ii) on the expression of specific receptors and (iii) cell type (Huber et al.,
2003; Nishiyama et al., 2003; Bartoe et al., 2006; McKenna et al., 2008). Although studies on
extracellular cues and their effects on neuronal guidance have been well documented, less is
known about the intracellular signaling mechanisms that regulate growth cone behavior. Thus,
investigating signaling pathways and the integration of different signals in the growth cone will
allow for a better understanding of mechanisms controlling neuronal pathfinding during
development and regeneration of the nervous system.
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Growth Cone Structure and Dynamics
Growth cones, located at the tip of extending neurites, were observed in fixed chick embryonic
tissues for the first time in the late 1800s by the Spanish neuroanotomist Ramon y Cajal. He
described growth cones as “battering rams” finding their way through many obstacles to reach
their targets, and already envisioned a guidance mechanism involving attractive gradients of
diffusible cues released from their targets (Cajal, 1890). In 1910, growth cones were observed in
embryonic neuronal tube explants by Ross Harrison (Harrison, 1910), and in vivo on growing
nerve fibers in the transparent tail of a frog by Speidel in 1930 (Speidel, 1941). It has been
shown that growth cones, isolated from their cell bodies in vivo, are still able to grow and
navigate correctly to their final destinations (Bray et al., 1978; Harris et al., 1987), suggesting
that growth cones themselves contain the machinery to sense and respond to guidance cues.
The growth cone is composed of three regions: (i) the central domain, which contains
microtubules and organelles, (ii) the lamellipodium, composed of a meshwork of filamentous
actin (F-actin), and (iii) finger like extensions, called filopodia, made of bundles of F-actin
(Smith, 1988; Huber et al., 2003) (Fig. 1.1). Guidance cues bind to receptors located on the
membrane of filopodia, which continuously extend and retract to explore their environment. This
area which is surveyed by the growth cone at any given point in time is called its ‘action radius’.
Therefore, the ability of a growth cone to be dynamic is critical for correct pathfinding and
application of drugs that interfere with filopodial dynamics result in pathfinding errors (Bentley
and Toroian-Raymond, 1986; Chien et al., 1993). During the journey toward their targets, growth
cone morphology and the speed of neurite advance changes at various points along their path
(Tosney and Landmesser, 1985; Bovolenta and Mason, 1987).
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Figure 1.1: Phase contrast image of a Helisoma trivolvis B5 growth cone.
The growth cone contains 3 domains, the central domain (C), the lamellipodia (L), and filopodia
(representative filopodia indicated by the arrows).
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Growth cones fasciculating with pioneer axons have a simple bullet shape and grow
faster, whereas growth cones reaching decision points become more complex, have more
filopodia and lamellipodia and advance slower. Once growth cones reach their target region,
their shape becomes thinner with many branches (Harris et al., 1987). As mentioned above,
filopodia are the sensing devices of the growth cone and it has been shown that removal of
filopodia will not prevent a growth cone from advancing but will affect correct navigation
(Bentley and Toroian-Raymond, 1986; Chien et al., 1993). The importance of filopodia, and
more specifically of single filopodia, in growth cone guidance has been demonstrated in vitro
and in vivo. For example, contact of a single filopodium with a laminin-coated area in the culture
dish or a guidepost cell results in the reorientation of the growth cone toward the contact point
(O'Connor et al., 1990; Letourneau, 1996). In Helisoma neurons, stimuli known to induce an
increase in the intracellular calcium concentration and/or changes in filopodial length, will cause
the same effect on isolated filopodia, suggesting that filopodia can act as autonomous units
(Davenport et al., 1993).
What are the mechanisms controlling growth cone dynamics? Pharmacological studies
identify F-actin as a key player in growth cone motility (Marsh and Letourneau, 1984;
Letourneau et al., 1987) F-actin is polymerized in growth cones from G-actin monomers that are
added at the plus end (barbed end) of F-actin at the leading edge of filopodia and lamellipodia.
Actin filaments are very dynamic, involving actin polymerization at the plus end, retrograde flow
toward the central domain (Zhou and Cohan, 2004), actin depolymerization at the minus end,
and recycling of actin subunits for further actin polymerization (Lin et al., 1996; Mallavarapu
and Mitchison, 1999; Jay, 2000; Suter and Forscher, 2000). Actin turnover has been shown to be
critical for growth cone motility during pathfinding. Removal of filopodia on Ti1 pioneer growth
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cones in the grasshopper limb in vivo by treatment with the actin depolymerizing agent,
cytochalasin, induced misguidance (Bentley and Toroian-Raymond, 1986). Errors in pathfinding
after treatment with cytochalasin were also observed in the Xenopus visual system, with retinal
axons missing the tectum (Chien et al., 1993). These experiments, in addition to emphasizing a
role of actin turnover in growth cone motility, suggest that filopodia are not necessary for neurite
advance itself, but for correct pathfinding in response to guidance cues. The rate of filopodial
elongation depends on both the rate of F-actin polymerization and retrograde flow (Mallavarapu
and Mitchison, 1999). During pathfinding, growth cones will exhibit a variety of behaviors, such
as collapse, and turning toward or away from gradients of guidance cues. These behaviors
involve reorganization of the actin cytoskeleton in addition to regulation of actin turnover.
Growth cones exposed to an attractive cue will have more and longer filopodia in the direction of
the cue (Bentley and O'Connor, 1994; Zheng et al., 1996; Gallo et al., 1997), creating an
asymmetrical cytoskeletal organization, which is critical for growth cone steering. Indeed,
depolymerization of F-actin on one side of a growth cone with a local gradient of cytochalasin
induces turning of the growth cone away from the gradient (Yuan et al., 2003).
Microtubules have been recently suggested to be more than a secondary player in growth
cone pathfinding (structural support for neurite advance), but instead to have a critical role in this
process (Dent and Kalil, 2001; Gordon-Weeks, 2004; Kalil and Dent, 2005). In the axon,
microtubules are organized in bundles and splay out once they enter the base of the growth cone,
where a few invade the lamellipodium and some may even enter individual filopodia (Tsui et al.,
1984; Gordon-Weeks, 1991; Sabry et al., 1991; Zhou and Cohan, 2004). Microtubules, like Factin, are dynamic polymers, switching between phases of growth and shrinkage, with tubulin
polymerization occurring at the plus end, which points toward the F-actin meshwork in the
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peripheral domain (Heidemann et al., 1981; Kirschner and Mitchison, 1986; Baas et al., 1988).
Pharmacological approaches have suggested a role for microtubule dynamics in growth cone
steering. Pretreatment of Xenopus spinal neurons with taxol or nocodazole, drugs known to
stabilize or destabilize microtubules, respectively, blocks the turning effect of glutamate and
netrin-1. Local stabilization of microtubules on one side of Xenopus growth cones induces
steering toward that side, whereas local destabilization induces turning away from the side
exposed to nocodazole (Buck and Zheng, 2002). The similarity between the effects of blocking
actin and microtubule dynamics, and the observation of interactions between these two polymers
in the lamellipodium and individual filopodia suggest a possible interaction between
microtubules and F-actin during growth cone steering by guidance cues.

Guidance Cues and the Molecular Machinery of Growth Cones
Rho GTPases and actin dynamics
Studies on fibroblasts have identified small GTP-binding proteins of the Rho subfamily (Rho
GTPases), such as Cdc42, Rac and Rho, as critical players in the formation of filopodia,
lamellipodia, focal adhesions and stress fibers, respectively (Ridley and Hall, 1992; Ridley et al.,
1992; Nobes and Hall, 1995; Mueller, 1999). Injection of active Cdc42 into fibroblasts induced
filopodial formation, whereas active Rac induced lamellipodial formation (Ridley et al., 1992;
Kozma et al., 1995; Nobes and Hall, 1995). Development of stress fibers and focal adhesions
were observed after injection of active Rho (Ridley and Hall, 1992; Nobes and Hall, 1995).
Furthermore, in the nervous system, Rho GTPases are temporally expressed during axonal
outgrowth in Drosophila, rats and chicken (Luo et al., 1994; Malosio et al., 1997; Threadgill et
al., 1997). Additionally, RhoA effectors promote growth cone collapse and neurite retraction
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(Wahl et al., 2000; Gallo and Letourneau, 2004). Rac-1 and Cdc42 have been found to regulate
filopodial and lamellipodial dynamics in growth cones, and neurite guidance (Kuhn et al., 1998;
Brown et al., 2000). During neuronal pathfinding, guidance cues bind and activate receptors on
filopodia, which in turn regulate growth cone actin dynamics by activating Rho GTPases (Gallo
and Letourneau, 1998; Dickson, 2001; Huber et al., 2003; Gallo and Letourneau, 2004). The
activity state of Rho GTPases is determined by the binding of guanine nucleotides. Binding of
GTP to Rho GTPases activates them, whereas GDP inactivates them. Two main classes of
proteins control Rho GTPases activity, guanine nucleotide exchange factors (GEF) and GTPase
activating factors (GAF). GEFs facilitate the exchange of GDP to GTP, which in turn activate
Rho GTPases, whereas GAFs turn off their signaling by enhancing the endogenous GTPase
activities of Rho GTPases (Hall, 1994; Dickson, 2001; Huber et al., 2003).
Rho GTPases integrate signaling from many guidance cues, leading to specific growth
cone behaviors such as turning, branching, and collapse by controlling actin polymerization,
branching, actin depolymerization and retrograde flow. Recent studies have unraveled the
mechanisms by which Rho GTPases regulate actin dynamics. Cdc42 and Rac induce actin
nucleation and branching by activating the Arp2/3 complex through the effectors neuronal
Wiskott-Aldrich Syndrome protein (N-WASP) and SCAR/WAVE, respectively (Machesky et
al., 1999; Rohatgi et al., 1999). Actin polymerization is controlled by (i) the protein profilin,
which binds to G-actin monomers, facilitating their addition at the plus end of F-actin and (ii) its
effectors, proteins from the VASP/Ena family, which in addition to activating profilin also
associate with the plus end of F-actin and prevent the binding of capping proteins (Suetsugu et
al., 1998; Bear et al., 2002). Actin depolymerization at the minus end involves the F-actin
severing protein, cofilin. The activity of cofilin is regulated by phosphorylation and
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dephosphorylation, with inactivation induced by phosphorylation through LIM kinase (LIMK)
(Arber et al., 1998; Yang et al., 1998), and activation caused by dephosphorylation via the
phosphatase Slingshot (Niwa et al., 2002). LIMK is activated by p21-activated kinase (PAK), the
effector of Cdc42 and Rac, and by ROCK, the effector of RhoA (Arber et al., 1998; Yang et al.,
1998). Rho GTPases control F-actin retrograde flow by regulating non-muscle myosin via
phosphorylation by ROCK or myosin light chain kinase (MLCK), the latter being inactivated by
PAK, the effector of Rac and Cdc42 (Amano et al., 1996; Sanders et al., 1999). To summarize,
during neuronal pathfinding, guidance cues can regulate growth cone behavior through
RhoGTPase signaling, which mediates the activation of actin binding proteins (ABPs).

Guidance cues and RhoGTPases
During development of the nervous system, guidance cues guide extending neurites by
regulating growth cone actin dynamics. However, it remains to be deteremined which
RhoGTPases mediate the effect of particular guidance cues. In this section I will briefly
introduce only the guidance cues known to mediate their effect via RhoGTPase signaling.
The diffusible factor netrin has been shown to act bifunctionally in vertebrates, being
attractive for spinal cord commissural axons to the floor plate and repulsive for trochlear motor
axons (Kennedy et al., 1994; Colamarino and Tessier-Lavigne, 1995). Furthermore, netrin
receptors have been identified: attractive receptors are UNC-40, DCC and Frazzled in C.elegans,
vertebrate and Drosophila respectively (Chan et al., 1996; Keino-Masu et al., 1996; Kolodziej et
al., 1996), whereas UNC-5 and UNC 40 have been shown to mediate repulsion in C. elegans
(Amano et al., 1996; Chan et al., 1996; Ackerman et al., 1997; Leonardo et al., 1997; Mueller,
1999). In vertebrates, netrin-1-DCC signaling involves the RhoGTPases, Rac and Cdc42.
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Coexpression of DCC, and dominant negative forms of Rac and Cdc42 in HEK 293T cells or
neuroblastoma cells blocks the effect of netrin-1 on filopodial number and cell morphology
(Shekarabi and Kennedy, 2002). Furthermore, Rac1 and Cdc42 activities have been shown to be
necessary for DCC-induced neurite outgrowth in N1E-115 neuroblastoma cells (Li et al., 2002).
Netrin-1 affects growth cone dynamics via cyclic nucleotides, and the intrinsic level of cyclic
nucleotides modulates the effect of netrin-1. For example, experiments using growth cone
turning assays indicated that high levels of cyclic adenosine monophosphate (cAMP) mediated
netrin-1 induced attraction, whereas low levels of cAMP mediated netrin-1 induced repulsion of
embryonic Xenopus spinal neurons (Ming et al., 1997; Song et al., 1997).
Semaphorins, which can be both diffusible and membrane bound, can also act as either
attractive or repulsive guidance cues (Messersmith et al., 1995; Shepherd et al., 1997; VarelaEchavarria et al., 1997). In vitro studies on chick dorsal root ganglion neurons suggest a role for
Rac1 in mediating collapsin1- or semaphorin3A-induced growth cone collapse (Jin and
Strittmatter, 1997). Activation of RhoA seems to be critical for semaphorin4-induced growth
cone collapse (Huber et al., 2003). Similar to netrin, semaphorin signaling involves cyclic
nucleotides. Indeed, cyclic guanosine monophosphate (cGMP) modulates the effect of
semaphorin3 on growth cone motility, because growth cone repulsion can be converted to
attraction by increasing the intracellular level of cGMP (Song and Poo, 1999).
Another type of repulsive cue, ephrins, which bind to their tyrosine kinase receptors
Ephs, play a role in the formation of topographic maps (Cheng et al., 1995; Drescher et al.,
1997), patterning of forebrain and hindbrain (Xu et al., 1995; Xu et al., 1996), and the formation
of certain commissures (Orioli et al., 1996; Park et al., 1997). EphA receptors interact with
glycosylphosphatidylinositol (GPI) anchored ephrin A ligands, whereas EphB receptors bind to

14
ephrin B transmembrane ligands (Frisen and Barbacid, 1997). A particularity of these ligands is
that their signaling is bidirectional, meaning that binding of ligands to receptors triggers
signaling in the cell expressing the receptor (forward signaling), as well as in the ligandexpressing cell (backward signaling) (Kullander and Klein, 2002). Ephrin signaling involves
RhoGTPase activation; for example, ephrin-A5 has been shown to induce growth cone collapse
of retinal ganglion cells though activation of RhoA and its effector ROCK (Wahl et al., 2000).
Furthermore, retinal axon retraction in response to ephrin-A2 involves RhoA and Rac1 signaling
(Gallo et al., 2002; Jurney et al., 2002).
Neurotrophins, such as nerve growth factor (NGF), brain derived neurotrophic factor
(BDNF), and neurotrophin 3 and 4 (NT-3 and NT-4) have been well documented to play a role in
neuronal growth and survival during the development of the nervous system in vivo (Huang and
Reichardt, 2001); however, recent studies in vitro suggest that they also have the ability to act as
potent guidance cues. For example, NGF induces attractive turning of chick dorsal root and
retinal axons (Gundersen and Barrett, 1979; Gallo et al., 1997). In addition, these four
neurotrophins have been shown to induce growth cone turning of Xenopus spinal neurons in vitro
(Song et al., 1997; Ming et al., 1999). Neurotrophins bind with high affinity to tropomyosin
related kinase (Trk) receptors, which are tyrosine kinase receptors. NGF binds to TrkA, BDNF to
TrkB and NT-3 to TrkC. Stimulation of TrkA by NGF induces the activation of Cdc42 and Rac,
as well as the inactivation of RhoA (Sebok et al., 1999; Yamaguchi et al., 2001; Nusser et al.,
2002). Inhibition of the RhoA effector, ROCK, blocks NGF induced growth cone steering
(Loudon et al., 2006). These results strongly suggest a role for RhoGTPases in NGF-mediated
regulation of neurite outgrowth. Neurotrophins also bind with low affinity to another type of
receptor, the p75 receptor. P75 has been suggested to bind RhoA directly and to inactivate it
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upon binding of neurotrophins (Yamashita et al., 1999). Indeed, BDNF induces filopodial
elongation on chick retinal growth cones by inactivating RhoA through p75 stimulation (Gehler
et al., 2004). As observed with netrin-1 and semaphorin, the attractive effect of BDNF and NGF
can be converted to repulsion by decreasing the cAMP level (Song et al., 1997).
As mentioned earlier, neurites can be guided by short range guidance cues through
contact with cues in the extracellular matrix (ECM), or cell adhesion molecules (CAM)
expressed on both pathfinding neurons and neighboring cells (Tessier-Lavigne and Goodman,
1996). Cell adhesion receptors include immunoglobulin (Ig) family members such as NCAM, as
well as cadherins and integrins. Binding of these receptors to ligands in the ECM or to CAM on
neighboring cells triggers signaling pathways that affect neurite outgrowth. Mitogen activated
protein kinase (MAPK) pathways have been well documented to mediate cell adhesion receptor
signaling (Tessier-Lavigne and Goodman, 1996; Huber et al., 2003). In addition to MAPK
pathways, integrins and cadherins can also activate RhoGTPase signaling (Clark et al., 1998;
Kaibuchi et al., 1999; Ren et al., 1999).

Role of the Second Messenger Calcium in Axonal Guidance
Importance of calcium in growth cone motility and steering
Calcium (Ca2+) is an important second messenger that relays guidance cues to regulate growth
cone motility and steering (Song and Poo, 1999; Gomez and Spitzer, 2000; Henley and Poo,
2004). The intracellular calcium concentration ([Ca2+]i) in the growth cone is regulated by
several mechanisms, such as influx through plasma membrane Ca2+ channels, release from
internal stores (mitochondria and endoplasmic reticulum) through inositol-3 phosphate (IP3) and
ryanodine sensitive channels, and extrusion through plasma membrane adenosine triphosphate
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dependent pumps and sodium-calcium exchangers (Lipscombe et al., 1988; Clapham, 1995;
Henley and Poo, 2004; Wen and Zheng, 2006). Calcium has been shown to play a role in neurite
outgrowth, but early studies from different research groups were not consistent and sometimes
even conflicting. Some groups demonstrated that Ca2+ facilitated neurite outgrowth (Nishi and
Berg, 1981; Suarez-Isla et al., 1984) while others suggested that Ca2+ prevented it (Bixby and
Spitzer, 1984; Mattson and Kater, 1987; Silver et al., 1989). An explanation for this range of
responses was provided by the hypothesis of a “Ca2+ set point” (Kater and Mills, 1991) stating
that within an optimal range of [Ca2+]i neurites grow at their maximal speed, but that changes of
[Ca2+]i below or above the optimal range will slow down or stop growth cone motility. In
addition to regulating neurite outgrowth, [Ca2+]i plays a critical role in growth cone steering.
Application of an electric field affects the speed of neurite advance of Xenopus spinal neurons
and mouse dorsal root ganglion neurons and induces growth cone steering toward the cathode
(Hinkle et al., 1981; Patel and Poo, 1982; Fields et al., 1990). Interestingly, the effect of electric
fields on growth cone motility is mediated by a local increase in [Ca2+]i (Bedlack et al., 1992;
Davenport and Kater, 1992).
Guidance cue-induced growth cone steering, such as seen with netrin-1, NGF, BDNF and
myelin associated glycoprotein (MAG), also requires Ca2+ signaling (Song et al., 1997; Hong et
al., 2000; Henley et al., 2004). For example, a gradient of netrin-1 has been shown to induce
growth cone attraction by increasing [Ca2+]i via calcium influx through voltage dependent Ca2+
channels (Hong et al., 2000; Niwa et al., 2002; Nishiyama et al., 2003). Furthermore, recent
studies have demonstrated a role of transient receptor potential (TRP) channels in netrin-1,
BDNF and MAG induced growth cone steering (Li et al., 2005; Shim et al., 2005; Wang and
Poo, 2005). Growth cone steering requires an asymmetric increase of [Ca2+]i in the growth cone.
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For example, local increases of [Ca2+]i in Xenopus and dorsal root ganglion growth cones by
using a gradient of ryanodine or Ca2+ ionophore respectively, is sufficient to induce growth cone
steering (Gundersen and Barrett, 1980; Hong et al., 2000). These results are further supported by
experiments using focal photolysis of caged Ca2+ to induce growth cone turning (Zheng, 2000).
Surprisingly a local increase in [Ca2+]i in growth cones induces both attraction and repulsion,
depending on the amplitude of the increase. Focal photolysis of caged Ca2+ in the presence of
extracellular Ca2+ induces attraction of growth cones, whereas when the resting level of [Ca2+]i is
decreased in the absence of extracellular Ca2+, the same focal release induces repulsion (Zheng,
2000). Gradients of netrin-1 and MAG induce growth cone attraction and repulsion, respectively,
by increasing [Ca2+]i on the side of the gradient. Netrin-1 causes a higher increase in [Ca2+]i than
MAG, mediated by both Ca2+ influx through plasma membrane Ca2+ channels and Ca2+-induced
Ca2+ release from internal stores, whereas MAG acts through Ca2+ release from internal stores
only (Hong et al., 2000; Nishiyama et al., 2003; Henley et al., 2004). To summarize, a global
increase in [Ca2+]i affects neurite outgrowth, whereas a local increase mediates growth cone
steering.
It is also important to note that transient increases in [Ca2+]i localized to filopodia have
been observed during neurite outgrowth in vitro, with the local increase in [Ca2+]i propagating to
the central domain, and leading to a global increase in [Ca2+]i (Gomez et al., 2001). Experiments
in our laboratory have investigated the effect of spatio-temporal increases in [Ca2+]i on filopodial
dynamics of Helisoma B5 neurons. Global and regional uncaging of Ca2+ in the growth cone
induced a global increase in filopodial length, whereas local release within an individual
filopodium induced elongation that was restricted to the stimulated filopodium (Cheng et al.,
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2002). These results suggest a critical role for spatio-temporal Ca2+ signaling in neuronal
pathfinding.

Calcium signaling
The effect of calcium signaling on neurite outgrowth and growth cone steering is mediated by
changes in cytoskeleton dynamics. A well documented effector of Ca2+ is the Ca2+ binding
protein, calmodulin (CaM). CaM is highly expressed in filopodia and the central domain of
growth cones, and is sensitive to [Ca2+]i just above basal calcium levels (Zucker, 1999).
Inhibition of CaM induces mistakes in pathfinding in vivo (VanBerkum and Goodman, 1995),
and prevents laminin-induced growth cone attraction in vitro (Kuhn et al., 1998). Calciumcalmodulin activates calcium/calmodulin-dependent kinases (CaMK) and the phosphatase
calcineurin (Henley and Poo, 2004). Uncaged Ca2+-induced filopodial elongation in Helisoma
B5 neurons is mediated by activation of CaM and calcineurin (Cheng et al., 2002). Furthermore,
recent studies in Xenopus and other organisms have shown that overexpression of active CaMKII
facilitates neurite outgrowth, whereas inhibition prevents it (Goshima et al., 1993; Kuhn et al.,
1998; Zou and Cline, 1999). Calcineurin also prevents neurite outgrowth in Xenopus spinal
neurons and promotes it in chick dorsal root ganglion neurons (Chang et al., 1995; Lautermilch
and Spitzer, 2000). Another protein mediating Ca2+ signaling is protein kinase C, which is
activated by calcium and phosphorylates a number of proteins, including GAP-43 (Liu and
Storm, 1990). Phosphorylation of GAP-43 by PKC results in the dissociation of GAP-43 from
CaM, allowing free CaM to be activated by Ca2+ (Liu and Storm, 1990). It is important to note
that phosphorylated GAP-43 stabilizes F-actin, whereas dephosphorylation by calcineurin
destabilizes it (He et al., 1997). Furthermore, PKC has been shown to mediate growth cone
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turning in Xenopus spinal neurons and growth cone dynamics in Helisoma B5 neurons (Cheng et
al., 2000; Xiang et al., 2002). Another downstream protein of Ca2+ signaling is myosin II, which
is activated by phosphorylation via Ca2+/CaM dependent myosin light chain kinase and/or by
ROCK (Amano et al., 1996; Dent and Gertler, 2003), and inactivated by RhoGTPases, Cdc42
and Rac (Sanders et al., 1999). To summarize, calcium is a critical second messenger regulating
growth cone dynamics during neuronal pathfinding.

Phosphatidylinositol-3-Kinase (PI-3K)
PI-3K signaling
PI-3K has been implicated in a variety of cellular activities, including cell survival, mitogenesis,
and differentiation (Krasilnikov, 2000; Rodgers and Theibert, 2002). There are three classes of
PI-3K: Class I contains a p110 catalytic subunit and a regulatory adapter subunit, and
preferentially

phosphorylates

phosphatidylinositol

4,5

biphosphate

[PtdIns(4,5)P2]

to

PtdIns(3,4,5)P3 (Vanhaesebroeck and Waterfield, 1999; Cantrell, 2001). Class II phosphorylates
PtdIns and PtdIns(4)P to PtdIns(3)P and PtdIns(3,4)P2 respectively, whereas class III
phosphorylates only PtdIns to PtdIns(3)P (Vanhaesebroeck and Waterfield, 1999; Cantrell,
2001). Class I PI-3K can be activated by receptor- and non-receptor tyrosine kinases, as well as
by G-protein coupled receptors (Stephens et al., 1994; Stoyanov et al., 1995; Lopez-Ilasaca et al.,
1997; Duronio et al., 1998; Vanhaesebroeck and Waterfield, 1999; Cantrell, 2001). PI-3K, in
turn, has two modes of action. First of all, it functions as a lipid kinase by phosphorylating the
3’-OH position on the inositol ring of several phosphoinositides, thereby producing inositol lipid
products, which are important mediators of intracellular signaling (Duronio et al., 1998;
Vanhaesebroeck and Waterfield, 1999; Cantrell, 2001). This signaling pathway leads to the
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stimulation of guanine nucleotide exchange factors for Rho-GTPases, as well as to the activation
of the PH-domain containing kinase, PDK-1, which in turn activates Akt (Alessi et al., 1997;
Downward, 1998; Meier and Hemmings, 1999; Vanhaesebroeck and Alessi, 2000). Secondly,
PI-3K functions as a protein kinase resulting in the activation of the Ras/Raf/Erk and Cdc42/Rac
pathways (Bondeva et al., 1998; Vanhaesebroeck and Waterfield, 1999; Krasilnikov, 2000). Both
the lipid and the protein kinase activities of PI-3K regulate downstream targets known to affect
actin cytoskeletal organization (Rodgers and Theibert, 2002), suggesting a potential role of PI3K in growth cone dynamics.

Role of PI-3K in the nervous system
Developing and adult rat brains express PI-3K (Ito et al., 1995; Bartlett et al., 1999; Rodgers and
Theibert, 2002) and upregulation of PI-3K has been observed after axonal crush and ischemia
(Ito et al., 1996; Kitagawa et al., 1999). An increase in PI-3K activity and protein level occurs in
amyotrophic lateral sclerosis (Wagey et al., 1998), whereas a decrease in PI-3K activity is
observed in Alzheimer’s disease (Zubenko et al., 1999). The function of PI-3K in neuronal
survival is well established (Yao and Cooper, 1995; Rodgers and Theibert, 2002). In addition to
its involvement in mediating cell survival, PI-3K has been reported to stimulate neurite
outgrowth in PC12 cells (Kita et al., 1998), to mediate ephrin A5 and slit-2 induced growth cone
collapse in chick retinal ganglion cells (Wong et al., 2004), and to be required for the NCAMmediated neurite outgrowth of primary neurons (Ditlevsen et al., 2003). In addition, PI-3K has
been shown to play a role in lamellipodial formation of PC12 cells (Posern et al., 2000) and in
the regulation of neuronal polarity (Shi et al., 2003; Menager et al., 2004). These effects are
likely mediated by changes at the level of the neuronal cytoskeleton. The mechanism by which
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PI-3K affects neurite outgrowth is presently unclear, but prominent targets downstream of PI-3K
include Akt (Protein kinase B), regulators of Rho-GTPase family members, and the
RAS/RAF/ERK pathway (Corvera and Czech, 1998; Duronio et al., 1998; Vanhaesebroeck and
Waterfield, 1999; Bishop and Hall, 2000; Krasilnikov, 2000; Cantrell, 2001). Studies have
shown that expression of a dominant inhibitory form of Akt increases NGF-induced neurite
outgrowth in PC12 cells (Bang et al., 2001; Piiper et al., 2002). Yet, pharmacological inhibition
of PI-3K reduces neurite outgrowth in mouse DRG and hippocampal neurons (Wu et al., 1998;
Edstrom and Ekstrom, 2003), as well as in PC12 cells (Jackson et al., 1996). Furthermore, PI-3K
activation by NGF has been shown to increase axon outgrowth in DRG neurons by inactivation
of GSK-3ß and subsequent involvement of the microtubule plus end binding protein APC (Zhou
et al., 2004), although NGF stimulation has also been reported to signal via the MAPK pathway
(Goold and Gordon-Weeks, 2005). To summarize PI-3K may regulate neurite outgrowth via Akt
and MAPK pathway.

Role of the Gaseous Second Messenger Nitric Oxide (NO) in the Nervous System
NO signaling
NO is a gas produced by the enzyme nitric oxide synthase (NOS), which is known to have 3
isoforms: neuronal (nNOS), inducible (iNOS) and endothelial (eNOS) (Garthwaite, 1991).
Activation of cells containing iNOS, such as macrophages, microglia and astrocytes, during
disease and injury leads to the production of NO (Hall, 1994; Cassina et al., 2002). Like other
free radicals, NO in high concentrations can be toxic due its formation of reactive nitrogen
species (RNS) such as peroxynitrite (ONOO-), via the reaction of nitric oxide and superoxide
(Lewen et al., 2000). A main target of NO is the enzyme soluble guanylyl cyclase (sGC), which
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once activated by the binding of NO to its heme moiety (Dierks and Burstyn, 1996), forms
cGMP. cGMP can increase [Ca2+]i by activating PKG, which in turn can activate ryanodinesensitive calcium stores located in the endoplasmic reticulum (Willmott et al., 1996; Looms et
al., 2001; Vicente et al., 2005). cGMP can also increase [Ca2+]i by activating cyclic nucleotidegated ion (CNG) channels located in the plasma membrane. This is achieved by cGMP elevating
the concentration of cAMP through inhibition of phosphodiesterase III (PDEIII) (Houslay and
Milligan, 1997; Tsukada et al., 2002; Jensen et al., 2004). Recent studies have reported a role for
Ca2+/Calmodulin in the formation of NO through activation of some NOS isoforms (Bredt and
Snyder, 1990; Cho et al., 1992; Li and Poulos, 2005). Other mechanisms of NO action are
exerted via nitrosylation of cysteine residues in proteins to produce S-Nitrosothiols (Arnold et
al., 1977; Stamler et al., 1992; Jaffrey et al., 2001; Ahern et al., 2002), and nitration of tyrosine
residues (Ischiropoulos, 1998). In addition to its effect on protein regulation, NO can also act on
DNA (Wink et al., 1991).

NO and the nervous system
In the central nervous system (CNS), NO has been described as a neuromodulator involved in
long-term potentiation during learning and memory (O'Dell et al., 1994; Brenman and Bredt,
1996; Son et al., 1996). Recent studies report that presynaptic plasticity induced during activitydependent synaptogenesis is regulated by NO (Nikonenko et al., 2003; Zhang et al., 2005). NO
has also been suggested to play an important role in the formation of retinal projections during
neuronal development in vivo (Williams et al., 1994; Cramer et al., 1996; Gibbs and Truman,
1998; Cramer and Sur, 1999; Ernst et al., 1999; Wildemann and Bicker, 1999; Wu et al., 2000).
For example, inhibition of nNOS by pharmacological blockers was shown to prevent the
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elimination of transient ipsilateral retinotectal projections in the chick visual system, and to
affect retinogeniculate projection patterns in ferret (Wu et al., 1994; Cramer and Sur, 1999).
Moreover, NO has been reported to be involved in neuronal differentiation and neurite
outgrowth. Neuronal differentiation of NGF-induced PC12 cells is dependent on NO (Peunova
and Enikolopov, 1995; Nakaya et al., 2000). However, the role of NO on neurite outgrowth is
controversial. Some groups have reported that NO induces growth cone collapse and neurite
retraction (Hess et al., 1993; Ernst et al., 1999; Gallo et al., 2002), and others have reported that
NO facilitates neurite outgrowth (Hindley et al., 1997; Poluha et al., 1997; Rialas et al., 2000).
During the development of the grasshopper embryo, NO, potentially released from epithelial
cells facing the basal lamina of the developing antenna, has been shown to regulate axonal
pathfinding of antennal pioneer neurons (Seidel and Bicker, 2000; Bicker, 2007). We have
shown previously that NO donors applied to identified Helisoma B5 neurons grown in vitro
results in an increase in filopodial length and a concomitant decrease in neurite outgrowth (Van
Wagenen and Rehder, 1999; Trimm and Rehder, 2004; Welshhans and Rehder, 2005),
suggesting that some of the developmental effects of NO described in the literature might result
from NO acting on neuronal growth cones. A recent study, in which NO donors were applied
focally to B5 growth cones, indeed confirmed that NO regulates filopodial motility locally at the
growth cone and that the NO signaling pathway included soluble guanylyl cyclase (sGC), protein
kinase G (PKG), cyclic adenosine diphosphate ribose (cADPR) and intracellular calcium release
from ryanodine sensitive stores (Welshhans and Rehder, 2005; Welshhans and Rehder, 2007). In
addition, a follow up study demonstrated that NO release from a single cell has a physiological
effect on growth cone dynamics of neighboring neurons in vitro (Tornieri and Rehder, 2007).
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NO has also been suggested to have pathological effects in neurodegenerative diseases
and in CNS injury (Ruan et al., 1995; Beckman et al., 2001; Tabner et al., 2002). Recents studies
have highlighted a controversy in the role of NO in neuronal regeneration. Upregulation of NOS
expression has been associated with the degeneration of spinal motoneurons (Wu and Scott,
1993; Wu et al., 1994; Wu, 1996) and with the death of Purkinje neurons (Chen and AstonJones, 1994) following injury. However, upregulation of NOS expression has also been
correlated with axonal regeneration after injury of cranial motoneurons (Yu, 1994). A
regenerative delay due to a decelerated Wallerian degeneration has been reported in NOS
knockout mice (Keilhoff et al., 2002). Recently, NO has also been demonstrated to promote
axonal regeneration following injury in locust embryos (Stern and Bicker, 2008). Furthermore,
iNOS and nNOS have been reported to have a neuroprotective role in the olfactory
neuroepithelium (Min et al., 2003), and peroxynitrite has been suggested to be involved in
cellular survival at low concentrations (Bolanos et al., 2004). The difference in cell types and
species used in the studies mentioned above may explain this discrepancy on the role of NO
following CNS injury.

Helisoma trivolvis as a Model System to Study Neuronal Pathfinding during Development
and Regeneration Following Injury
Transplantation of embryonic neuronal tissues (Low et al., 1982), solid grafts (Lindvall et al.,
1990), and neuronally derived cells (Baron-Van Evercooren, 1994) has been used with limited
success in mammalian models to enhance neuronal regeneration beyond the glial scar. Because
regeneration occurs in the CNS of Helisoma trivolvis, it is a well-established model system to
study neuronal regeneration following injury in vivo (Murphy and Kater, 1980; Berdan et al.,
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1990; Murrain et al., 1990; Berdan and Easaw, 1992) and in vitro (Rehder et al., 1992; Geddis
and Rehder, 2003; Geddis and Rehder, 2003). Helisoma has a simple, well characterized nervous
system, and the large size (up to 100 µm) and consistent position of the neuronal cell bodies in
its ganglia permits (i) the injection of tracer dyes into identified neurons to assess changes in
morphology during regeneration (Murphy and Kater, 1980; Berdan et al., 1990; Berdan and
Easaw, 1992), and (ii) isolation of identified neurons into primary culture. Identification of
individual neurons in different animals by their morphology, color, location and size allows for
elimination of variability due to a heterogeneous population of neurons. In addition, the ability to
maintain organ and cell culture allows for complete control over the environment during the
experiment. To address the specific aims of my dissertation, I performed experiments using
primary cell culture of two identified neurons (neurons B5 and B19) located in the buccal
ganglion, which controls the feeding behavior of the snail.

Morphology and characteristic of B5 and B19 buccal neurons
In vivo one single axon of the B5 neuron exits the buccal ganglion through the esophageal nerve
trunk and branches near the salivary gland (i) to innervate the esophagus via the gastric nerve
and (ii) to innervate the buccal mass via the dorsobuccal nerve trunk (Berdan RC, 1989; Berdan
et al., 1990). B5 neurons are cholinergic and nitergic neurons, in which electrical activity is
modulated by glutamate (Haydon et al., 1990; Zoran et al., 1990; Van Wagenen and Rehder,
2001; Scannell et al., 2008). The B19 neuron innervates the supralateral radular tensor muscle of
the buccal mass (Berdan RC, 1989; Zoran et al., 1990). B19 neurons are cholinergic neurons, in
which glutamate affects electrical activity, and serotonin and dopamine decrease neurite
outgrowth (Haydon et al., 1984; Cohan et al., 1987; McCobb et al., 1988; Haydon et al., 1990;
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Murrain et al., 1990; Zoran et al., 1990; Davenport et al., 1993; Scannell et al., 2008). The fact
that B19 neurons do not express nNOS and sGC, as opposed to B5 neurons, makes them a good
control in experiments investigating the role of NO (Van Wagenen and Rehder, 2001; Tornieri
and Rehder, 2007).

Helisoma growth cones
The large size of growth cones from neurons grown in culture (up to 50 µM) makes Helisoma
trivolvis a great system to study growth cone dynamics. Neurons cultured in defined medium
(without growth factors) form short neurites with large non-motile growth cones (Williams and
Cohan, 1994), suggesting that growth cone formation is an intrinsic property, whereas neurite
advance requires growth factors. These large growth cones permit the investigation of
cytoskeletal changes during growth cone dynamics (Cohan et al., 2001; Zhou and Cohan, 2001).
On the other hand, culturing neurons in conditioned medium (containing growth factors) induces
the formation of extended neurites tipped with motile growth cones (Williams and Cohan, 1994),
suggesting that neurite extension requires growth factors. The morphology and motility of B5
and B19 growth cones differ, with B5 growth cones having shorter and more filopodia than B19
growth cones (Haydon et al., 1985). In terms of outgrowth, B5 growth cones advance faster than
B19 ones (Haydon et al., 1985). To summarize, the simplicity of its nervous system, the large
size and accessibility of its neurons, and the fact that its CNS can regenerate leads to the use of
H. trivolvis as a favorable system to investigate neuronal pathfinding.
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Chapter 2 : Control of Neurite Outgrowth and Growth Cone Motility by
Phosphatidylinositol-3-Kinase
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Abstract
Phosphatidylinositol-3-kinase (PI-3K) has been reported to affect neurite outgrowth both
in vivo and in vitro. Here we investigated the signaling pathways by which PI-3K affects neurite
outgrowth and growth cone motility in identified snail neurons in vitro. Inhibition of PI-3K with
wortmannin (2 µM) or LY 294002 (25 µM) resulted in a significant elongation of filopodia and
in a slow-down of neurite outgrowth. Experiments using cytochalasin and blebbistatin, drugs that
interfere with actin polymerization and myosin II activity, respectively, demonstrated that
filopodial elongation resulting from PI-3K inhibition was dependent on actin polymerization.
Inhibition of strategic kinases located downstream of PI-3K, such as Akt, ROCK and MEK, also
caused significant filopodial elongation and a slow-down in neurite outgrowth. Another growth
cone parameter, filopodial number, was not affected by inhibition of PI-3K, Akt, ROCK, or
MEK. A detailed study of growth cone behavior showed that the filopodial elongation induced
by inhibiting PI-3K, Akt, ROCK and MEK was achieved by increasing two motility parameters:
the rate with which filopodia extend (extension rate) and the time that filopodia spend
elongating. Whereas the inhibition of ROCK or Akt (both activated by the lipid kinase activity of
PI-3K) and MEK (activated by the protein kinase activity of PI-3K) had additive effects,
simultaneous inhibition of Akt and ROCK showed no additive effect. We further demonstrate
that the effects on filopodial dynamics investigated were calcium-independent. Taken together,
our results suggest that inhibition of PI-3K signaling results in filopodial elongation and a slowdown of neurite advance, reminiscent of growth cone searching behavior.
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Introduction
During development growth cones play an important role in guiding neuronal processes
to their targets. Growth cones function by integrating intracellular signals that are elicited by the
binding of extracellular cues to membrane-bound or intracellularly located receptors, and by
translating these signals into a coordinated motor output that results in directed neurite advance.
The filopodia on growth cones undergo continuous cycles of extension and retraction, thereby
placing their receptors at varying distances from the growth cone proper and resulting in changes
in the ‘sensory radius’ of the growth cone. Filopodial length and neurite outgrowth are under the
control of extracellular cues, and several treatments, mainly acting through an increase in the
intracellular calcium concentration have been demonstrated to cause a transient increase in
filopodial length (Davenport and Kater, 1992; Rehder and Kater, 1992; Cheng et al., 2002) and a
decrease in neurite extension (Cohan et al., 1987; Mattson and Kater, 1987; Lankford and
Letourneau, 1989; Kater and Mills, 1991; Neely, 1993).
Phosphatidylinositol-3-kinase (PI-3K) has been implicated in a variety of cellular
activities, including cell survival, mitogenesis, and differentiation (Krasilnikov, 2000; Rodgers
and Theibert, 2002). PI-3K is activated by binding to receptor- and non-receptor tyrosine
kinases, as well as by G-protein coupled receptors, and its activation is known to affect multiple
targets (Raffioni and Bradshaw, 1992; Soltoff et al., 1992; Soltoff et al., 1992; Duronio et al.,
1998; Wymann and Pirola, 1998; Virdee et al., 1999; Krasilnikov, 2000; Cantrell, 2001). In
addition to its involvement in mediating cell survival, PI-3K has been reported to stimulate
neurite outgrowth in PC12 cells (Kita et al., 1998), to mediate ephrin A5 and slit-2 induced
growth cone collapse in chick retinal ganglion cells (Wong et al., 2004), and to be required for
the NCAM-mediated neurite outgrowth of primary neurons (Ditlevsen et al., 2003). In addition,
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PI-3K has been shown to play a role in lamellipodial formation of PC12 cells (Posern et al.,
2000) and in the regulation of neuronal polarity (Shi et al., 2003; Menager et al., 2004). These
effects are likely mediated by changes at the level of the neuronal cytoskeleton. The mechanism
by which PI-3K affects neurite outgrowth is presently unclear, but prominent targets downstream
of PI-3K include Akt (PKB), regulators of Rho-GTPase family members, and the
RAS/RAF/ERK pathway (Corvera and Czech, 1998; Duronio et al., 1998; Vanhaesebroeck and
Waterfield, 1999; Bishop and Hall, 2000; Krasilnikov, 2000; Cantrell, 2001). To determine
whether the effect of PI-3K activity on neurite outgrowth might be explained by PI-3K affecting
growth cone motility through its effects on the neuronal cytoskeleton, we here studied several
key targets within the larger PI-3K signaling cascade to investigate the signaling pathway by
which PI-3K affects the actin cytoskeleton of neuronal growth cones.
PI-3K has a double-enzymatic activity, that of a lipid kinase and a protein kinase (Dhand
et al., 1994; Krasilnikov, 2000). The protein kinase activity regulates the PKC, Ras/ERK, and
Rac/JNKK/JNK signaling pathways, whereas the lipid kinase activity controls the Akt antiapoptotic signaling pathway and the activity of Rho kinase (ROCK) (Krasilnikov, 2000; Cantley,
2002). By using two inhibitors of PI-3K, wortmannin and LY 294002, we show that PI-3K
activity is involved in regulating both neurite outgrowth and filopodial dynamics. We further
show that this regulation involved members of the lipid kinase (ROCK or Akt) and the protein
kinase (MEK) pathways of PI-3K signaling. Fast time course studies of filopodial dynamics
showed that the rapid filopodial elongation seen after different treatments was achieved mainly
by changes in two parameters of filopodial motility: increases in the extension rate and in the
time that individual filopodia spend extending. By employing drugs that interfere with actin
polymerization and myosin II activity, we further provide evidence that filopodial elongation
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seen after inhibition of PI-3K is mainly due to an increase in actin polymerization at the barbed
end, and not through inhibition of retrograde actin flow. Because filopodial elongation and a
decrease in the rate of neurite outgrowth seen after inhibition of PI-3K in this study are similar to
growth cone behavior observed at “decision points” during pathfinding in vivo (Taghert et al.,
1982; Tosney and Landmesser, 1985; Holt, 1989), these data suggest that signaling through PI3K could be of critical importance for growth cone motility, and that a lack of stimulation or
inhibition of the PI-3K pathway could result in slow-down and search behavior in advancing
neurites.

Methods and Materials
Neuronal culture and image acquisition
Identified B5 neurons were dissected from Helisoma trivolvis buccal ganglia and plated
for neuronal culture. Neurons used for filopodial experiments were plated on poly-L-lysine
(hydrobromide, MW 70,000-150,000, 0.25mg/ml; Sigma, St. Louis, MO) coated glass cover
slips that were glued to the bottom of 35 mm cell culture dishes (Falcon 1008). Neurons used for
outgrowth experiments were plated onto either the same glass dishes described above, or onto
poly-L-lysine coated plastic cell culture dishes as described in Trimm and Rehder (2004). Cells
were kept at room temperature and used 24-48 hours after plating. Neurons were grown in
conditioned medium (CM) prepared by incubating two snail brains per milliliter in defined
medium (DM) for 3-4 days. DM was produced by dilution of Leibowitz L-15 medium (Gibco
#41300, Grand Island, NY) with distilled water to obtain the appropriate ionic composition and
contained final concentrations of: 46 mM NaCl, 1.8 mM KCl, 1.5 mM MgCl2, 4.1 mM CaCl2, 10
mM HEPES, 50 µg gentamycin/ml, 0.15 mg glutamate/ml in distilled water (pH=7.3). Growth
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cones were viewed through 100x oil immersion objectives on either an Axiovert (Carl Zeiss,
Thornwood, NY) or a Sedival (aus Jena, Germany) microscope. Neurite outgrowth was imaged
through a 40x objective on a Sedival microscope. Images were captured with a cooled CCD
camera (CH250, Photometrics, Tucson AZ) or a regular CCD camera (Model: C-72, MIT Dage,
Michigan City, IN). Images were digitized on a frame grabber (Scion LG-3, Scanalytics, Fairfax,
VA) and analyzed with “Scion Image” software (Scion Corporation; Frederick, Maryland) on a
Power Macintosh (Apple Computer, Cupertino, CA) or a Compaq Presario (Hewlett-Packard
Company, Palo Alto, CA).

Pharmacological agents
LY 294002 (PI-3K inhibitor), PD 98059 (MAP kinase kinase inhibitor), Akt inhibitor,
blebbistatin (nonmuscle myosin II ATPase inhibitor), and cytochalasin B (actin polymerization
inhibitor) were dissolved in DMSO to obtain stock concentrations of 20, 50, 45, 50 mM and 60
µM respectively. Wortmannin, another PI-3K inhibitor, was dissolved in methanol to a stock
concentration of 1 mM. The Rho-kinase inhibitor Y27632 was dissolved in water to a stock
concentration of 10 mM. All agents were purchased from Calbiochem (San Diego, CA).

Design and analysis of filopodial experiments
Observation of growth cone behavior, specifically, changes in filopodial length and
filopodial number, was performed at defined times before and after the addition of
pharmacological agents, which were added to the dish through a complete medium exchange.
Immediately before each experiment, drugs were premixed in 2 mL of L-15 medium to obtain
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final concentrations. Control experiments were performed for each of the solvents used in the
reconstitution of pharmacological agents and, in each case, the final solvent concentration did
not exceed 0.2%. At these concentrations, the solvents had no significant effect on filopodia.
Images were captured before (-5 and 0 min) and at defined times after (2, 5, 10, 15, 20, and 30
minutes) a complete medium exchange, which introduced the experimental condition.
Digitized images of growth cones were analyzed by tracking all filopodia from image to
image in previously defined intervals, and by measuring the length of filopodia from their base to
their tip.

The filopodial base was defined as the transition point where the lamellipodial

peripheral domain meets the organelle rich central domain of the growth cone. Filopodial length
was measured from phase contrast images using the software package “Scion Image.” All
filopodia on a growth cone were measured and those values were averaged to result in a measure
of ‘mean filopodial length’ for each growth cone. These values were expressed as a percentage
change normalized to the time point t = 0 just before any drug treatment to compensate for the
fact that individual growth cones varied in size and filopodial length.
Fast time-course experiments were performed on single growth cones by tracking
individual filopodia from image to image as previously described (Van Wagenen et al., 1999).
Images were acquired every 30 seconds during 7 minutes before treatment (Pre) and 10 minutes
after treatment (Post). This experimental design allows for determination of the parameters of
filopodia dynamics, such as the time a filopodium spends extending, retracting, or being stable.
Moreover, the extension and retraction rates of individual filopodia can be measured with this
approach. Filopodia were classified as extending or retracting if their individual filopodial length
increased or decreased by 0.4 µm in 30 seconds. Filopodia that did not meet this criterion were
considered as stable. Filopodia extension and retraction rates were expressed in µm/30 sec.
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Design and analysis of neurite outgrowth experiments
Images of neurons were taken at 20 minutes intervals for a total of 2 hours per
experiment as previously described (Trimm and Rehder, 2004). Neurite outgrowth was
determined by measuring neurite length starting from a fixed point in the dish (e.g. soma) and
measuring the distance to the growth cone’s central domain using the software package “Scion
Image.” Neurites that advanced less than 6 µm during the control period (one hour before
treatment) or that fasciculated with other neurites during the experiment were excluded from
analysis. Outgrowth during the first hour of treatment following drug addition was measured by
subtracting neurite length at t = 0 from t = 60. Outgrowth during the second hour of treatment
following drug addition was measured by subtracting neurite length at t = 60 from t = 120. In
order to introduce the experimental condition, 0.2 mL of conditioned medium was removed from
the dish, a drug was premixed in this volume, and the 0.2 mL was subsequently added back to
the dish to obtain the final concentration. Solvents used in the reconstitution of pharmacological
agents were tested by themselves in control experiments and had no significant effect on neurite
outgrowth.

Calcium imaging
Calcium imaging was performed as described previously (Rehder and Cheng, 1998; Van
Wagenen and Rehder, 1999). Briefly, Helisoma B5 neurons were pressure injected (Picospritzer;
General Valve Corp., Fairfield, NJ) with the calcium indicator dye, Fura-2 pentapotassium salt (10
mM in water; Molecular Probes, Eugene, OR). Cells were used 20-30 minutes after injection in
order to allow for the calcium indicator to diffuse. Fura-2 was excited at two excitation wavelengths
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(340±10 nm and 380±10 nm) and after calibration, the ratio of the fluorescent images captured was
converted into an estimated [Ca2+]i according to Grynkiewicz et al. (1985).

Actin labeling and analysis of actin fluorescence
Growth cones were fixed and stained according to Cohan et al. (2001) with the variation that
rhodamine phalloidin was used (Molecular Probes) at a concentration of 0.165 µM. Growth cones
were viewed through a 100x oil immersion objective on a Zeiss Axiovert inverted microscope
equipped with a rhodamine filter set (Omega Optical, Brattleboro, VT). Images were acquired using
a cooled Photometrics CCD camera, and stored on a Macintosh computer. A camera exposure time
of 200 ms was used for all images. Image intensity was analyzed with Scion Image software (Scion
Corporation) and two measurements were taken to quantify f-actin content in growth cones. To
calculate the mean fluorescent intensity of f-actin in the growth cone’s p-region, a line was drawn
outlining the lamellipodial region and the measured fluorescence averaged. The fluorescent intensity
of actin bundles forming the core of filopodia was analyzed according to Cohan et al. (2001).
Briefly, a line was drawn across individual actin bundles within the middle of the lamellipodium.
The peak intensities for each bundle (the average of 3 pixels for each bundle) were determined and
this procedure repeated for at least 5 filopodia per growth cone, except when that was impossible
due to loss of filopodia (condition with 500 nM Cytochalasin B). These values were then expressed
as an average peak intensity for each growth cone. Staining was done in parallel for different
experimental conditions to minimize differences in staining intensity between dishes.
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Statistical analysis
For filopodial experiments, significance between conditions was determined by performing
an analysis of variance (1-way ANOVA or ANOVA with time as repeated measures), and with a ttest for dependent and independent samples, with SuperANOVA (Abacus Concepts, Berkeley, CA).
Fisher’s protected least significant difference (PLSD) test was used for post-hoc tests of statistical
significance. For neurite outgrowth, fast time-course and actin labeling experiments, significance
between conditions was determined by performing a Student’s t-test (for unpaired or paired samples)
with Excel (Microsoft; Redmond, WA). Significant differences are indicated as: *p ≤ 0.05, **p ≤
0.01, ***p ≤ 0.001.

Results
PI-3K inhibition induces filopodial elongation and a slow-down in the rate of neurite advance
To investigate the effect of PI-3K activity on growth cone motility, B5 neurons were
treated with two specific PI-3K inhibitors, wortmannin and LY 294002. Treatment with LY
294002 (25 µM) resulted in filopodial elongation as early as five minutes after addition of the
drug, with maximal overall filopodial elongation of 37.6 ± 6.1% reached after 20 min (Fig. 2.1A
and 1B) (see Supplemental time-lapse movie). This elongation effect was highly significantly
when compared to the control condition (p ≤ 0.001), in which solvent alone (DMSO 0.125%)
was applied. Interestingly, the number of filopodia on a given growth cone, another parameter of
growth cone morphology, was not affected by LY 294002 (p = 0.70) (Fig. 2.1C). To confirm
independently the effect of PI-3K inhibition on growth cone morphology, neurons were treated
with a second PI-3K inhibitor, wortmannin (Wort, 2 µM). At this concentration, the overall
filopodial length increased significantly by 46.6 ± 9.6% after 20 min (p ≤ 0.001) compared to the
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Figure 2.1: Inhibition of PI-3K results in an increase in filopodial length by increasing the
time filopodia spent extending and the filopodial extension rate, but has no effect on
filopodial number.
(A) Phase-contrast images of a representative B5 growth cones 5 minutes before (pre) and 9
minutes after treatment with the PI-3K inhibitor, LY 294002 (25 µM). Note that a majority of
filopodia elongate (representative filopodia are indicated with an arrow). Scale bar = 12µm. (see
Supplemental time-lapse movie of this growth cone). (B) Treatment of B5 growth cones with LY
294002 (25 µM) caused a significant increase in overall filopodial length as early as 5 min after
addition of the drug. Exposure of growth cones to DMSO (0.125%), the solvent in which LY
294002 was dissolved, had no effect on filopodial length (p = 0.70). The effect of LY 294002
was significantly different from the control condition (p ≤ 0.001), as indicated in parentheses
behind the treatment group. PI-3K inhibition with a second PI-3K inhibitor, wortmannin (2 µM),
also caused a rapid significant increase in overall filopodial length when compared to its
methanol control (0.2%) (p ≤ 0.001). (C) The number of filopodia on a given growth cone was
not affected by either LY 294002 (25 µM) or wortmannin (2 µM) treatment and there also was
no significant difference between the two drug treatments (p = 0.644). (D) Inhibition of PI-3K
with 25 µM LY 294002 resulted in a significant increase in the time filopodia spent extending in
the first five minutes following drug addition (Post) in comparison to 7 min prior to drug
addition (Pre). The time spent stable and retracting were not significantly affected by LY 294002
(25 µM) treatment (p = 0.12 and p = 0.36 respectively). (E) Treatment with 25 µM LY 294002
caused a significant increase in the filopodial extension rate in comparison to its control (Pre, 7
min prior to drug addition) (p ≤ 0.01). Filopodial retraction rate was not affected by LY 294002
(25 µM) treatment (p = 0.45).
For all experiments the number of growth cone studied per condition is given as ‘n’ and listed
behind each experimental condition. Statistical significance between conditions is symbolized by
asterisks as follows: *P ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
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solvent control (Fig. 2.1B). Note that the filopodial elongation induced by LY 294002 and
wortmannin were not significantly different (p = 0.98), suggesting that the two inhibitors blocked
PI-3K to a similar degree when used at these concentrations. Consistent with the observation
made with the other PI-3K inhibitor (LY 294002), treatment with wortmannin also had no
significant effect on filopodial number (p = 0.64) (Fig. 2.1C).
Growth cone filopodia frequently switch between episodes of extension and retraction within
seconds. Whereas the measurements above captured the average length and number of filopodia at
fixed time points that were separated by several minutes, we next wanted to investigate the dynamic
process of filopodial elongation in more detail. Filopodial length changes can be explained by
underlying changes in dynamic filopodial parameters, such as the amount of time individual
filopodia spend extending, retracting or not moving (stationary), as well as the rates at which
filopodia extend and retract. To investigate which parameters of filopodial dynamics were affected
to explain the filopodial elongation observed after inhibition of PI-3K, individual filopodia on single
growth cones were tracked every 30 sec during a 7 min pretreatment period (Pre), and during the
initial 4-5 minutes after treatment that included the phase of rapid filopodial elongation (Post).
Treatment with LY 294002 significantly increased the time that filopodia spent extending from 39.5
± 1.6 % before treatment to 52.0 ± 3.6 % after treatment (p ≤ 0.05) (Fig. 2.1D). The times filopodia
were stationary and spent retracting were not affected (p = 0.12 and p = 0.36 respectively) (Fig. 2.1
D). The filopodial extension rate was significantly increased from 1.26 ± 0.06 µm/30 sec before
treatment (Pre) to 1.72 ± 0.1 µm/30 sec after treatment with LY 294002 (p ≤ 0.01) (Fig. 2.1E).
Treatment with the PI-3K inhibitor did not affect the filopodial retraction rate (p = 0.45) (Fig. 2.1E).
These results suggested that the overall filopodial elongation seen in response to PI-3K inhibition
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resulted from the combination of an increase in the extension rate and the time that filopodia spent
extending.
We next investigated whether PI-3K inhibition would also affect neurite outgrowth.
Indeed, treatment with LY 294002 significantly reduced the neurite outgrowth rate from 18.2 ±
1.7 µm in the hour prior to treatment to 8.5 ± 2.6 µm (p ≤ 0.001) in the first hour after treatment
(Fig. 2.2). A further significant decrease in outgrowth to 3.2 ± 1.7 µm resulted in the second hour
of treatment. Taken together, these results suggested that a decreased stimulation, or inhibition of
the PI-3K pathway, could serve as an acute slow-down and search signal for migrating growth
cones.

MEK, Akt and ROCK regulate filopodial dynamics and neurite outgrowth
To investigate the pathway by which PI-3K might regulate growth cone motility, we
pharmacologically inhibited major targets downstream of PI-3K with the assumption that their
inhibition should mimic the effect of PI-3K inhibition and result in filopodial elongation and/or a
slow down in neurite outgrowth. PI-3K has a double enzymatic activity, acting as a protein
kinase and a lipid kinase (Krasilnikov, 2000; Cantley, 2002) (Fig. 2.3). Therefore, we wanted to
investigate which of the two activities might be involved in controlling filopodial dynamics and
neurite outgrowth.
We first inhibited Akt and ROCK, which are activated by the lipid kinase activity of PI3K. Akt was blocked with the Akt inhibitor (80 µM) and ROCK was inhibited with Y27632 (10
µM) (Fig. 2.3). Treatment with Akt inhibitor and Y27632 increased filopodial length by 28.4 ±
2.4% and 23.6 ± 2.4% respectively in comparison to the control condition (p ≤ 0.001) (Fig.
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Figure 2.2: Inhibition of PI-3K results in a slow-down of neurite outgrowth.
Inhibition of PI-3K with 25 µM LY 294002 resulted in a significant decrease in neurite
outgrowth in the first hour following drug addition (p ≤ 0.001). A further significant decrease
was seen in the second hour following drug addition (p ≤ 0.001 as compared to the hour prior to
drug addition). Note that addition of the solvent control (DMSO) by itself had no effect on
neurite outgrowth.
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Figure 2.3: Investigated signaling pathways by which PI-3K may regulate growth cone
dynamics.
PI-3K is activated by multiple effectors. The PI-3K signaling pathway is bifurcated and has two
branches, resulting from its lipid- and protein kinase activities. Through its lipid kinase activity,
PI-3K phosphorylates phosphatidylinositol (PI) and its phosphorylated derivatives. Then
phosphoinositides activate the RhoA/ROCK pathway, and the phosphoinositide-dependent
kinase (PDK), which in turn activates Akt. Through its protein kinase activity (in gray), PI-3K
binds directly to Ras and Rac-Cdc42, leading to the activation of MEK. Kinases investigated in
this study are in bold typeface and underlined. Inhibitors are indicated in italics.
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Figure 2.4: Regulation of filopodial dynamics by Akt and ROCK. (A-F)
The involvement of the lipid kinase activity of PI-3K was tested by strategically inhibiting key
kinases downstream of PI-3K activity (see Fig. 2.3). (A, B) Two targets of the PI-3K lipid
activity, namely Akt and ROCK, were inhibited with Akt inhibitor, and with Y27632
respectively. (A) Both Akt inhibitor (80 µM) and ROCK inhibitor, Y27632 (10 µM),
significantly increased overall filopodial length in comparison to their respective control
conditions, 0.175% DMSO and 0.1% water (dH2O) (both p ≤ 0.001). (B) Filopodial number was
not significantly altered by the inhibition of Akt with Akt inhibitor (80 µM) (p = 0.44) or by the
inhibition of ROCK with Y27632 (10 µM) (p = 0.07) when compared to controls. (C) Inhibition
of Akt with Akt inhibitor (80 µM) resulted in a significant increase in the time filopodia spent
extending in the first five minutes following drug addition (Post) compared to the 7 min control
time window prior to drug addition (Pre) (p ≤ 0.05). The times spent stable and retracting were
not significantly affected by Akt inhibitor (80 µM) treatment (p = 0.05 and p = 0.85
respectively). (D) Treatment with 80 µM Akt inhibitor caused a significant increase in filopodial
extension rate compared to control (Pre, 7 min prior to drug addition) (p ≤ 0.05). The filopodial
retraction rate was not affected by Akt inhibitor (80 µM) (p = 0.24). (E) Inhibition of ROCK
with Y27632 (10 µM) resulted in a significant increase in the time filopodia spent extending (p ≤
0.01), as well as a significant decrease in the time filopodia spent being stable (p ≤ 0.05). The
time spent retracting was not significantly affected by Y27632 (10 µM) treatment (p = 0.09). (F)
Treatment with 10 µM Y27632 caused a significant increase in filopodial extension and
retraction rates compared to controls (Pre, 7 min prior to drug addition) (p ≤ 0.01 and p ≤ 0.05
respectively).
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2.4A). Filopodial number was not affected by these treatments (p = 0.44 and p = 0.07
respectively) (Fig. 2.4B).
Next, we investigated which parameters of filopodial dynamics were affected by
inhibiting targets of the lipid kinase pathways of PI-3K. Therefore, we monitored filopodial
dynamics in fast time-course experiments as described earlier. Treatment with Akt inhibitor
increased significantly the time filopodia spent extending from 32.9 ± 1.6% before treatment
(Pre) to 42.3 ± 2% after treatment (Post) (p ≤ 0.05) (Fig. 2.4c). The times filopodia were
stationary and spent retracting were not affected by Akt inhibitor (p = 0.05 and p = 0.85
respectively) (Fig. 2.4C). The filopodial extension rate was also significantly increased from 1.04
± 0.04 µm/30 sec before treatment (Pre) to 1.33 ± 0.08 µm/30 sec after treatment (p ≤ 0.05; Fig.
2.4D). The ROCK inhibitor, Y27632 induced a significant increase in the time filopodia spent
extending from 39.3 ± 1.2% before treatment (Pre) to 51.2 ± 3% after treatment (Post) (p ≤ 0.01;
Fig. 2.4E). The time filopodia were stationary was significantly decreased from 26.9 ± 1.4% to
19.8 ± 2.1% (p ≤ 0.05) as compared to controls (Pre), whereas the time filopodia spent retracting
was not affected (p = 0.09) (Fig. 2.4E). Inhibition of ROCK also increased both the extension
and the retraction rates from 1.34 ± 0.07 µm / 30 sec to 1.73 ± 0.08 µm / 30 sec, and from 1.35 ±
0.05 µm / 30 sec to 1.51 ± 0.03 µm / 30 sec respectively (p ≤ 0.01 and p ≤ 0.05) (Fig. 2.4F).
The effect of inhibition of Akt and ROCK on neurite outgrowth was studied next. When
Akt was inhibited, neurite outgrowth was not affected in the first hour following drug addition
(16.2 ± 2.8 µm in the hour prior to drug addition and 13.6 ± 3.2 µm in first hour following drug
addition; Fig. 2.5A). However, in the second hour following drug addition, neurite outgrowth
was significantly slowed to 6.7 ± 3.0 µm (p ≤ 0.001 as compared to the hour prior to drug
addition). When ROCK was inhibited with Y27362 neurite outgrowth also was not affected in
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Figure 2.5: Regulation of neurite outgrowth by Akt and ROCK.
(A) Inhibition of Akt with Akt inhibitor (80 µM) did not significantly affect neurite outgrowth in
the first hour following drug addition. However, neurite outgrowth was slowed significantly in
the second hour following drug addition (p ≤ 0.001). (B) Inhibition of ROCK with 10 µM
Y27362 did not significantly affect neurite outgrowth in the first hour after drug addition.
However, neurite outgrowth was slowed significantly in the second hour following drug addition
(Student’s t-test, **p ≤ 0.01).
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the first hour following drug addition (20.5 ± 2.1 µm in the hour prior to drug addition and 18.8
± 2.6 µm in first hour following drug addition; Fig. 2.5B). However, in the second hour
following drug addition, neurite outgrowth was significantly decreased to 12.0 ± 2.6 µm (p ≤
0.01 as compared to the hour prior to drug addition). Taken together, these results are consistent
with the idea that the lipid kinase activity of PI-3K is involved in controlling filopodial dynamics
and neurite outgrowth through Akt and ROCK. To determine whether the decreases in neurite
outgrowth rates observed in the first or second hour after the inhibition of PI-3K, Akt and ROCK
were due to an adverse effect of the long-term exposure of the drugs on filopodial dynamics, we
measured the dynamic parameters of filopodia after 2 hrs of treatment with LY 294002, Akt
inhibitor and Y27632 (Table 2.1).
A comparison of filopodial behaviors (time filopodia spend extending, stationary, or
retracting) revealed that there were no significant differences between these filopodial behaviors
before and two hours after treatment, with the exception of the Akt inhibitor resulting in
filopodia spending more time retracting, and Y 27632 resulting in filopodia spending less time
stationary and more time retracting (Table 2.1). Moreover significant long term effects of these
drugs on filopodial extension and retraction rates when comparing these parameters before and
two hours after treatment. These results suggest that filopodia remained motile during long-term
drug treatment and that the decrease in neurite outgrowth rate observed in response to LY
294002, Akt inhibitor and Y27632 treatments likely results from mechanisms other than
affecting filopodial dynamics. We next inhibited MAP kinase kinase (MEK), which is activated
by the protein kinase activity of PI-3K (Fig. 2.3). After treatment with specific MEK inhibitor
PD 98059 (40 µM), the filopodial length increased by 23.0 ± 3.1% (Fig. 2.6A), and this
elongation was significant when compared to the control group (p ≤ 0.001), which showed no
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Table 2.1: Comparison of filopodial parameters before and two hours after drug
treatments.
*p ≤ 0.05 compared to control (Pre).
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Figure 2.6: Regulation of growth cone filopodia by MEK inhibition.
(A) Treatment of B5 neurons with the MEK inhibitor PD 98059 (40 µM) to inhibit the protein
kinase branch of PI-3K caused a significant overall increase in filopodial length as early as 5 min
after addition of the drug. PD 98059 was washed out in an exchange with defined medium after
15 min of treatment. Exposure of growth cones to DMSO (0.08%), the solvent in which PD
98059 was applied, had no effect on filopodial length, and the treatment group was significantly
different from the control (p ≤ 0.001). (B) Treatment with PD 98059 (40 µM) had no significant
effect on filopodial number when compared to the control group (p = 0.50). (C) The time
filopodia spend extending significantly increased within the first five minutes following PD
98059 (40 µM) addition in comparison to control (7 min before drug addition) (p ≤ 0.05). No
differences were observed in the times filopodia spent stable and retracting (p = 0.21 and p =
0.50 respectively). (D) The filopodial extension rate was significantly increased after MEK
inhibition with PD 98059 (40 µM) in comparison to control (before drug addition, “Pre”) (p ≤
0.05). The filopodial retraction rate was not affected (p = 0.98).
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filopodial length change. The number of filopodia on a growth cone was not affected by the
inhibition of MEK (p = 0.50) (Fig. 2.6B), which was consistent with the lack of effect on
filopodial number after inhibiting PI-3K. It is important to note that PD 98059 started to
crystallize after 15 minutes of application, at which time the drug was washed out through an
exchange with defined medium. Thus time points after the initial ten minutes have to be taken
with caution, although a return of filopodial length towards pretreatment levels observed after
washout of the drug indicated some reversibility of the drug treatment. Note that the tendency to
crystallize precluded studies on neurite outgrowth employing this drug.
The investigation of dynamic changes in filopodial length revealed that PD 98059
significantly increased the time that filopodia spent extending from 37.4 ± 1.6 % before
treatment to 44.9 ± 2.2 % after treatment (p ≤ 0.05) (Fig. 2.6C). The time filopodia were
stationary or spent retracting was not affected (p = 0.21 and p = 0.50 respectively) (Fig. 2.6C).
The filopodial extension rate was significantly increased from 1.39 ± 0.12 µm/30 sec before
treatment (Pre) to 1.87 ± 0.12 µm/30 sec after MEK inhibition (p ≤ 0.05), whereas the filopodial
retraction rate was not affected (p = 0.98) (Fig. 2.6D). These results suggested that MEK activity
has a strong effect on filopodial length and might serve as a regulator of actin dynamics in
Helisoma growth cones.

Both activities of PI-3K act together to regulate filopodial dynamics
Because the inhibition of individual targets of the lipase and kinase activities of PI-3K
(Akt, ROCK, and MEK) each induced a smaller overall effect on filopodial elongation (~ 2028%) than seen after PI-3K inhibition itself (~ 46%), we next wanted to investigate if MEK, Akt,
and ROCK might interact to affect filopodial dynamics. To test this possibility, we treated B5
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neurons with various combinations of the following inhibitors: MEK inhibitor PD 98059 (40
µM), Akt inhibitor (80 µM), and ROCK inhibitor Y27632 (10 µM). Interestingly, filopodia
elongated by 42.3 ± 6.0% after 15 min of combined treatment with ROCK and MEK inhibitors,
and by 46.6 ± 5.2% when all three inhibitors were combined. Whereas these values were not
significantly different from each other and from treatment with the PI-3K inhibitor itself, they
were significantly larger than those obtained when each inhibitor was applied separately (Fig.
2.7). Note that there was no additive effect when the two kinases in the lipid kinase branch (Akt
and ROCK) were inhibited simultaneously (Fig. 2.7).

Growth cone behavior is not mediated by altering [Ca2+]i
PI-3K and its downstream targets have been shown to regulate the intracellular calcium
concentration ([Ca2+]i) in different systems (Blair et al., 1999; Macrez et al., 2001; Singleton and
Bourguignon, 2002). An elevation in [Ca2+]i in B5 growth cones results in filopodial elongation
(Rehder and Kater, 1992; Cheng et al., 2002) and a slow down in neurite outgrowth (Cohan et
al., 1987; Mattson and Kater, 1987). Thus it was important to investigate whether the filopodial
elongation observed after inhibition of the PI-3K signaling pathway was actually due to an
increase in [Ca2+]i resulting from the pharmacological treatment or if the effect was Ca2+independent. Employing the calcium indicator dye, fura-2, we detected no increase in the [Ca2+]i
in B5 growth cones after inhibition of PI-3K with wortmannin (2 µM), of Akt with Akt inhibitor
(80 µM) and of ROCK with Y27632 (10 µM) (Fig. 2.8). However, because the crystals that
formed 15 minutes after treatment with MEK inhibitor PD 98059 (40 µM) were autofluorescent,
we were unable to measure the [Ca2+]i for this condition during the second half of the
experiment. In the first 10 minutes before crystal formation, however, no increase in [Ca2+]i was
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detected. Depolarization of B5 neurons with a high K+ containing medium (34 mM KCl) resulted
in a significant increase in [Ca2+]i in B5 growth cones from 59 ± 2 nM at rest to maximal levels
of 128 ± 5 nM five minutes after treatment (p ≤ 0.001) (Fig. 2.8), demonstrating that the calcium
indicator fura-2 calcium was functional, and that a high K+ medium elevated [Ca2+]i to levels
consistent with observations in previous studies on the same cell type (Rehder and Cheng, 1998).

PI-3K regulates actin dynamics
Filopodia are composed of bundles of filamentous (f-) actin (Gordon-Weeks,
1987) and the barbed ends, where net addition of monomeric actin occurs, are located towards
the filopodial tip. Theoretically, filopodial elongation could result from: (i) an increase in actin
polymerization at the barbed end, (ii) a decrease in retrograde flow of f-actin without affecting
the normal net addition of monomeric actin at the barbed end, or (iii) a combination of both (Fig.
2.9A). In initial experiments we wanted to obtain a qualitative assessment of the contribution of
these mechanisms to filopodial length changes in untreated growth cones. Blebbistatin (Bleb)
was employed to inhibit the ATPase activity of nonmuscle myosin II (Straight et al., 2003) and
thereby block its potential contribution to the retrograde f-actin flow (Fig. 2.9A). Addition of
blebbistatin (100 µM) resulted in a gradual increase in filopodial length over time which reached
55.5 ± 17.9% after 30 min of treatment when compared to its control (DMSO) (p ≤ 0.01) (Fig.
2.9B), consistent with the notion that barbed end addition would continue in the absence of
retrograde flow, creating a net increase in f-actin filament length (Fig. 2.9A). Cytochalasin B
(Cyto B) was used to interfere with the addition of monomeric actin to the barbed end of factin.While Cyto B has been shown to result in the depolymerization of f-actin (Forscher and
Smith, 1988), we used Cyto B at a concentration (30 nM) that had no net effect on overall
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Figure 2.7: Both activities of PI-3K interact to regulate filopodial dynamics.
B5 neurons were treated with the following inhibitors either separately or in combinations, and
filopodial elongation was assessed 15 min after treatment. Treatment with PI-3K inhibitor LY
294002 (25 µM), Akt inhibitor (80 µM), ROCK inhibitor Y27632 (10 µM), and MEK inhibitor
PD 98059 (40 µM) induced overall filopodial elongation of 34.8 ± 7.9%, 25.7 ± 3.5%, 23.6 ±
2.3%, and 18.7 ± 3.4%, respectively. Filopodia elongated by 42.3 ± 6.0% when one kinase each
of the lipid- and protein kinase branch was inhibited together (ROCK and MEK inhibitors).
Simultaneous inhibition of Akt, ROCK and MEK resulted in filopodial elongation of 46.6 ±
5.2% and had no significant additional effect over inhibiting ROCK and MEK simultaneously.
The combinatorial effects were not significantly different from treatment with the PI-3K
inhibitor itself (p = 0.08), but significantly larger than when Akt inhibitor (80 µM) (p ≤ 0.01),
ROCK inhibitor, Y27632 (10 µM) (p ≤ 0.001), and MEK inhibitor, PD 98059 (40 µM) (p ≤
0.001) were applied separately. Note that there was no additive effect when the two kinases in
the lipid kinase branch (Akt and ROCK) were inhibited simultaneously. The control condition
denotes a final concentration of 0.125% DMSO (as used for LY 294002 (25 µM)), and this
control was not significantly different from controls for the other solvents used (not shown).
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Figure 2.8: Growth cone behavior was not mediated by altering [Ca2+]i.
Measurements of [Ca2+]i with the Ca2+ indicator fura-2 in response to various treatments used in
this study show that the inhibition of PI-3K and its downstream targets had no significant effect
on [Ca2+]i. A control treatment with high KCl (34 mM) increased [Ca2+]i to maximum levels of
128 nM after 5 min (p ≤ 0.001).

Estimated calcium concentration (nM)

61

2 µM Wort, n = 15
80 µM Akt inhibitor, n = 15
10 µM Y27632, n = 12
40 µM PD 98059, n = 14
34 mM KCl, n = 14 (***)

150
120
90
60
30
0
-10

0

10
20
Time (min)

30

62
Figure 2.9: Filopodial elongation resulting from PI-3K inhibition requires actin
polymerization.
(A) Model of filopodial length changes. Filopodial length is mainly regulated by actin
polymerization/depolymerization events at the barbed end and the retrograde flow by which factin is transported centrally (left). The curved arrow indicates actin polymerization onto the
barbed (+) end of f- actin, which would result in filopodial elongation. Arrows pointing to the
right symbolize actin polymerization and arrows pointing to the left symbolize retrograde flow.
The middle panel shows the net effect of various experimental treatments on overall filopodial
length. The right panel shows the hypothesized relative contributions (indicated by the length of
the arrows) of actin polymerization and retrograde flow on filopodial length under these
experimental conditions. See text and (B) for details. (B) Inhibition of ATPase activity of
nonmuscle myosin II with blebbistatin (100 µM) resulted in a gradual increase in filopodial
length over time that was significant when compared to its control (DMSO) (p≤ 0.01). The
inhibitor of actin polymerization, cytochalasin B, at the low concentration of 30 nM had no net
effect on filopodial length (p = 0.67). Combined treatment with cytochalasin B (30 nM) and
blebbistatin (100 µM) blocked filopodial elongation induced by blebbistatin treatment alone (p ≤
0.05). Inhibition of PI-3K with wortmannin (2 µM) resulted in net filopodial elongation, and this
effect was of a similar magnitude as observed with blebbistatin treatment. Wortmannin (2 µM) in
the presence of blebbistatin (100 µM) induced a larger effect on filopodial elongation when
compared to wortmannin and blebbistatin applied separately (p ≤ 0.001). Filopodial elongation
observed after wortmannin treatment was blocked by 10 minutes preincubation with 30 nM
cytochalasin B (p ≤ 0.01). (C) Effect on filopodial length from (B) after 10 minutes of treatment.
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filopodial length (Fig. 2.9 and Geddis et al., 2004). This result suggested that barbed end addition
was slowed by Cyto B to a degree that it was equal and opposite to the effect of retrograde flow.
When neurons were incubated in blebbistatin plus Cyto B the change in filopodial net length seen
with blebbistatin treatment alone was significantly blocked (p ≤ 0.05) (Fig. 2.9B and C), suggesting
that when plus-end addition cannot occur, the filopodial elongation that is seen with blebbistatin
alone is blocked, demonstrating the important role of actin polymerization for filopodial elongation.
To confirm that the total f-actin content was not affected by the treatment with 30 nM Cyto
B, we employed a fluorescently labeled mushroom toxin, rhodamine phalloidin, which binds to factin. Overall, growth cones treated with 30 nM Cyto B for 30 minutes appeared no different from
control growth cones (Fig. 2.10A). However, treatment with a higher concentration of Cyto B (500
nM) resulted in an obvious decrease in f-actin staining and a loss of filopodia (Fig. 2.10A).
Quantification of the intensity of f-actin staining within the lamellipodial P-region of growth cones,
however, revealed a small decrease in the intensity of staining in growth cones treated with 30 nM
Cyto B when compared to control growth cones (from 79.4 ± 4.8 to 65.1 ± 4.4 fluorescence units;
Fig. 2.10B; p ≤ 0.05, t-test). Treatment with 500 nM Cyto B showed a large reduction in f-actin
staining in the P-region (to 37.7 ± 3.0) (Fig. 2.10A and B; p ≤ 0.001, t-test). When f-actin content of
individual f-actin bundles (forming the core of filopodia) was measured (see Methods for details), no
difference between control growth cones and those treated with 30 nM Cyto B was found (Fig.
2.10C; p = 0.23, t-test). Growth cones treated with 500 nM Cyto B, however, showed a significant
loss in actin bundle intensity (from 110.0 ± 4.4 to 58.2 ± 3.9; Fig. 2.10C; p ≤ 0.001, t-test). These
results suggested that although 30 nM Cyto B slightly reduced the amount of f-actin within the Pregion of the growth cone, the f-actin content within filopodia was not measurably affected.
We next wanted to use the tools developed above to investigate whether PI-3K inhibition
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Figure 2.10: A low concentration of cytochalasin B (30 nM) does not affect filopodial actin
bundles, but slightly reduces overall f-actin staining intensity within the p-region.
Growth cones received one of three treatments (L-15 medium exchange (Control), 30 nM Cyto B
in L-15, or 500 nM Cyto B in L-15) for 30 minutes and were subsequently fixed in
parformaldehyde/glutaraldehyde and reacted with rhodamine phalloidin. (A) Growth cones that
received the 30 nM Cyto B treatment look indistinguishable from control growth cones regarding
overall morphology, as well as number and intensity of fluorescent F-actin bundles visible in the
growth cone. Note the noticeable loss of f-actin staining and filopodia in growth cones treated
with 500 nM Cyto B. Scale: 10 µm. (B) Intensity of f-actin staining in the p-region was
significantly reduced (from 79.4 ± 4.8 to 65.1 ± 4.4) by treatment with 30 nM Cyto B (p ≤ 0.05
as compared to Control). Treatment with 500 nM Cyto B reduced the intensity of f-actin
staining within the p-region to an even greater extent (to 37.7 ± 3.0; p ≤ 0.001 as compared to
Control). (C) Actin bundle intensity was not affected by treatment with 30 nM Cyto B (p = 0.23
as compared to Control). However, treatment with 500 nM Cyto B significantly reduced actin
bundle intensity from 110.0 ± 4.4 to 58.2 ± 3.9 (p ≤ 0.001 as compared to Control).
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resulted in filopodial elongation by increasing g-actin addition to the barbed end and/or by
inhibiting f-actin’s retrograde flow. Because the magnitude of filopodial elongation seen after
treatment with either wortmannin (to block PI-3K) or blebbistatin (to block retrograde flow) was
similar, (approximately 25-30% for both at 10 min) (Fig. 2.9B and C) it was possible that PI-3K
inhibition blocked retrograde flow. To test this hypothesis, wortmannin was applied in the
presence of blebbistatin. Interestingly, the effect on filopodial elongation was as large or even
larger than the numerical sum of the effects seen with either wortmannin or blebbistatin
treatment alone, reaching a 63 ± 8% increase in filopodial length after 10 min (p ≤ 0.01 and p ≤
0.05 compared to wortmannin and blebbistin alone) (Fig. 2.9B and C). This observation was
consistent with a mechanism by which wortmannin, increased filopodial length by increasing
actin polymerization at the barbed end. To investigate this likely mechanism further, we
inhibited PI-3K in the presence of Cyto B with the assumption that if PI-3K inhibition increased
actin polymerization onto the barbed end, we should be able to block the effect on filopodial
elongation in the presence of Cyto B. Whereas wortmannin caused an increase in filopodial
length of 25.8 ± 6.4% after 10 min, this effect was inhibited significantly after a 10 minutes
preincubation with 30 nM Cyto B (p ≤ 0.01) (Fig. 2.9B and C). This result suggested that actin
polymerization is the major factor by which PI-3K inhibition causes filopodial elongation.
Moreover the observation that there was no significant difference in the effects of treatment with
Cyto B plus wortmannin and with Cyto B by itself further supported the hypothesis that the PI3K inhibitor, wortmannin, increased filopodial length by increasing actin polymerization at the
barbed end.
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Discussion
Phosphatidylinositol-3-kinase (PI-3K) is central to many signaling pathways and has been shown
to function in cellular events such as cell survival, mitogenesis, differentiation and motility
(Duronio et al., 1998; Krasilnikov, 2000; Cantrell, 2001; Rodgers and Theibert, 2002). PI-3K can
be activated by receptor tyrosine kinases, non-receptor tyrosine kinases, and G-protein coupled
receptors (Stephens et al., 1994; Stoyanov et al., 1995; Lopez-Ilasaca et al., 1997; Duronio et al.,
1998; Vanhaesebroeck and Waterfield, 1999; Cantrell, 2001) but the mechanism by which PI-3K
affects neurite outgrowth is not well understood. Here we set out to investigate whether the effect
of PI-3K on neurite outgrowth might be explained by its action on the actin cytoskeleton in
neuronal growth cones.

PI-3K signaling events regulate filopodial dynamics and neurite outgrowth
Inhibition of PI-3K with wortmannin induced a rapid increase in filopodial length.
Filopodial elongation was observed at micromolar concentrations of wortmannin at which this
drug is not solely specific for PI-3K but can also affect PI-4K (Rodgers and Theibert, 2002). We
do not think that this activity interfered with PI-3K inhibition, because the same increase in
filopodial length was observed after treatment with a second, more specific PI-3K inhibitor, LY
294002. The fact that two different specific inhibitors induced the same effect on filopodial
length strongly suggests that PI-3K activity regulates filopodial dynamics. The study of the
dynamic parameters of filopodia, by tracking individual filopodia at 30 second intervals, showed
that the overall filopodial elongation induced by PI-3K inhibition was produced by an increase in
the time individual filopodia spent extending and by an increase in the extension rate of
individual filopodia.
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In addition to its effect on filopodia, treatment with the specific PI-3K inhibitor, LY 294002, also
caused a significant decrease in the rate of neurite outgrowth in the first and second hour of PI3K inhibition (Fig. 2.2). This decrease in outgrowth likely resulted from a mechanism other than
affecting filopodial motility, since filopodial dynamic parameters were virtually unchanged
before and two hours after treatment with the PI-3K inhibitor. Instead, it is reasonable to assume
that the PI-3K inhibitor acted on microtubules, because neuronal growth rates are dependent on
microtubule dynamics (Bamburg et al., 1986; Gordon-Weeks, 1991) and recent evidence
suggests that PI-3K activity can regulate microtubules (Zhou et al., 2004; Zhou and Snider,
2005).
Our results on the role of PI-3K signaling on neurite outgrowth are in agreement with studies
on other cell types. Pharmacological inhibition of PI-3K reduces neurite outgrowth in mouse
DRG and hippocampal neurons (Wu et al., 1998; Edstrom and Ekstrom, 2003), as well as in
PC12 cells (Jackson et al., 1996). On the other hand, PI-3K activation by NGF has been shown
to increase axon outgrowth in DRG neurons by inactivation of GSK-3ß and the involvement of
the microtubule plus end binding protein APC (Zhou et al., 2004), although NGF stimulation has
also been reported to signal via the MAPK pathway (Goold and Gordon-Weeks, 2005). Taken
together, inhibition of PI-3K elicits filopodial elongation and a concomitant decrease in neurite
advance, a phenomenon we have previously described to occur in response to treatment with
nitric oxide (Trimm and Rehder, 2004) and termed ‘slow down and search’ behavior.

ROCK, Akt, and MEK regulate filopodial dynamics and neurite outgrowth
PI-3K can be activated by receptor- and non-receptor tyrosine kinases, as well as by Gprotein coupled receptors (Stephens et al., 1994; Stoyanov et al., 1995; Lopez-Ilasaca et al.,
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1997; Duronio et al., 1998; Vanhaesebroeck and Waterfield, 1999; Cantrell, 2001). PI-3K, in
turn, has two modes of action. It functions as a lipid kinase by phosphorylating the 3’-OH
position on the inositol ring of several phosphoinositides, thereby producing inositol lipid
products, which are important mediators of intracellular signaling (Duronio et al., 1998;
Vanhaesebroeck and Waterfield, 1999; Cantrell, 2001). This signaling pathway leads to the
stimulation of guanine nucleotide exchange factors for Rho-GTPases, as well as to the activation
of the PH-domain containing kinase, PDK-1, which in turn activates Akt (Alessi et al., 1997;
Downward, 1998; Meier and Hemmings, 1999; Vanhaesebroeck and Alessi, 2000) (Fig. 2.3).
Secondly, PI-3K functions as a protein kinase resulting in the activation of the Ras/Raf/Erk
pathway (Bondeva et al., 1998; Vanhaesebroeck and Waterfield, 1999; Krasilnikov, 2000).
Given the complexity of PI-3K signaling, we here concentrated on three key kinases
downstream of PI-3K activity, namely ROCK, Akt, and MEK. Inhibition of any of these kinases
led to an overall increase in filopodial length, which resulted from an increase in both the
extension rate and the time filopodia spent extending. This finding was somewhat unexpected,
since it suggested that all three kinases were able to affect filopodial length and could play a role
in regulating growth cone dynamics during neuronal pathfinding (Fig. 2.3). The finding that the
simultaneous inhibition of Akt, ROCK and MEK mimicked the inhibition of PI-3K itself, and
induced a stronger filopodial elongation than when each kinase was inhibited individually,
suggested that the three pathways might interact to regulate actin dynamics. Interestingly,
simultaneous inhibition of the two kinases in the lipid kinase branch of PI-3K activity, namely
ROCK and Akt, had no additive effect, indicating that their actions may have a common
downstream element. Inhibition of one member each of the lipid kinase (ROCK) and protein
kinase pathways (MEK), however, resulted in an additive effect, suggesting that ROCK and
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MEK might affect filopodial length by different pathways that converge on elements regulating
actin dynamics (Fig. 2.3).
Akt is crucial to cell survival and the inhibition of Akt has been demonstrated to cause
cell death (Dudek et al., 1997). Since cell death is a process occurring on a much longer time
scale than the effects on filopodial length, we were less concerned that the filopodial response
could be a consequence of apoptosis in response to Akt inhibition. Rather, the time scale of
minutes indicated a direct signaling pathway involving the cytoskeleton locally.
In addition to the effects on filopodial behavior, we found that inhibition of two of the
downstream targets of the lipid kinase pathway, Akt or ROCK, resulted in a decrease in neurite
outgrowth in the second hour following drug addition (Fig. 2.5A and B). This late onset of an
effect on neurite outgrowth, compared to an effect on filopodial elongation observed within
minutes, suggested that filopodial elongation could occur without a concomitant decrease in
neurite outgrowth. As such, the slow-down and search behavior seen in this study can be divided
into two behaviors: “slow-down” and “search” (Fig. 2.11). As observed with both ROCK and
Akt inhibition, it is possible for a growth cone to elongate its filopodia over a short time course
(the “search” behavior) while maintaining a constant outgrowth speed. Yet, at other times these
behaviors can be coupled into the “slow-down and search” behavior that is seen with PI-3K
inhibition (Fig. 2.1B, Fig. 2.2) in the first hour of drug addition. Given that the treatments in this
study were long-term and may not reflect shorter and probably more physiologically relevant
episodes of kinase activation/inhibition, one could envision scenarios in which changes in
filopodial length and neurite outgrowth rates could either be regulated independently or in
conjunction, depending on the signaling cues received by the pathfinding growth cone. RhoA, an
activator of ROCK, has been shown to have opposite effects on neurite outgrowth depending
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on the cell type and the stage of outgrowth studied (Kranenburg et al., 1997; Threadgill et al.,
1997; Kuhn et al., 1999; Sebok et al., 1999). In agreement with ROCK promoting neurite
outgrowth, inactivation of RhoA has been shown to slow the rate of neurite outgrowth in NGFprimed differentiating PC12 cells (Sebok et al., 1999).
While we found that inhibition of Akt resulted in a slowing of neurite outgrowth, other
recent studies reported the opposite effect, namely that expression of a dominant inhibitory form
of Akt increased NGF induced neurite outgrowth in PC12 cells (Bang et al., 2001; Piiper et al.,
2002). This difference in results may be explained by the fact that while we investigated neurite
outgrowth on already extended neurites, the other studies focused on neurite initiation. It is, thus,
possible that Akt may affect neurite initiation and neurite maintenance differently, as has been
reported for RhoA (Sebok et al., 1999).

PI-3K signaling events alter filopodial length by regulating actin dynamics
Changes in filopodial length mainly result from a change in the balance of actin
polymerization and depolymerization at the ends of bundled f-actin polymers in filopodia, and by
altering the rate of retrograde f-actin flow (Lin et al., 1996; Mallavarapu and Mitchison, 1999).
In an attempt to determine which of these mechanisms were involved in producing filopodial
elongation after PI-3K inhibition, we used several drugs known to interfere with actin
polymerization (cytochalasin B) and myosin II activity (blebbistatin), the latter being implicated
in driving the retrograde actin flow (Brown and Bridgman, 2003). Our finding that the filopodial
elongation induced by PI-3K inhibition was blocked after pretreatment with cytochalasin B
demonstrated that PI-3K activity controls actin dynamics. More specifically, the results are in
agreement with the hypothesis that inhibition of PI-3K increases actin polymerization at the
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barbed end, although possible effects of PI-3K on actin depolymerization at the pointed end
cannot be ruled out. Alternatively, elongation could come about by a decrease or stoppage of
retrograde flow (Jay, 2000) and no change at the barbed end. This possibility was made less
likely by the finding that inhibition of the myosin II ATPase activity with blebbistatin, which
would block retrograde flow and result in an increase in filopodial length, showed an additive
affect when combined with PI-3K inhibition, resulting in an increase in filopodial length of
greater than 60%. Taken together our results suggest that while filopodial elongation can be
achieved independently by inhibiting myosin II activity or by increasing the addition of g-actin
to the barbed end, the filopodial elongation in response to PI-3K inhibition can be explained best
by an increase in actin polymerization. This result is supported further by a report on retinal
ganglion neurons in which filopodial elongation elicited by inhibition of either ROCK or myosin
II were additive, making it unlikely that ROCK acted through myosin II (Gehler et al., 2004).
Actin associated proteins, such as profilin and cofilin, control actin dynamics (Pollard and
Cooper, 1986; Stossel, 1989). Profilin inhibits actin assembly at the barbed end by binding and
sequestering actin monomers (Stossel, 1989). Phosphoinositides prevent the profilin-actin
monomer association by binding to profilin, with Ptdins(3,4)P2 (PIP2) having a higher affinity
than Ptdins(3,4,5)P3 (PIP3) (Goldschmidt-Clermont et al., 1991; Lu et al., 1996). Moreover,
profilin affinity for actin monomers has been shown to be increased by PI-3K dependent
phosphorylation (Sathish et al., 2004). Therefore filopodial elongation induced by PI-3K
inhibition could be due to an increase in profilin-PIP2 binding and to a decrease in
phosphorylated profilin. Actin polymerization could also be increased by preventing barbed end
capping through profilin binding proteins of the Ena/VASP family (Bear et al., 2002; Krause et
al., 2003) which are localized to the tips of filopodia (Lanier et al., 1999).
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Filopodial elongation observed after ROCK inhibition is consistent with two recent studies
on chick retinal neurons, in which BDNF binding to p75 neurotrophin receptors induces
filopodial elongation by inactivating the ROCK effector, RhoA in retinal ganglion neurons
(Gehler et al., 2004; Gehler et al., 2004). Filopodial elongation also resulted when ROCK was
inhibited directly.

Moreover, the effect of BDNF was shown to be mediated through an

activation of the complex cofilin - actin-depolymerizing factor (referred to as ADF/cofilin) and
not though an action of ROCK on myosin II activity. ADF/cofilin is an important regulator of
actin dynamics (Gungabissoon and Bamburg, 2003), as it disassembles actin monomers from the
pointed end and severs actin filaments, thereby producing more barbed ends in the process (Chen
et al., 2000). Whether activation of ADF/cofilin is involved in filopodial elongation in response
to PI-3K inhibition in B5 neurons is presently unclear.

A calcium-independent form of slow down and search behavior
In an earlier study that investigated the effect of nitric oxide (NO) on growth cone behavior,
we described the increase in filopodial length coupled with a slow-down in neurite advance as
‘slow-down and search’ behavior (Trimm and Rehder, 2004). Interestingly, NO acted via soluble
guanylyl cyclase and led to an increase in the free intracellular calcium concentration [Ca2+]i. In
the present study, we performed Ca2+-imaging experiments and found no measurable changes in
[Ca2+]i with any of the drug treatments, suggesting that a ‘slow-down and search’ behavior can
also be elicited in a Ca2+-independent fashion. Thus, a Ca2+ dependent (NO) and a Ca2+
independent (PI-3K) pathway appear to converge onto cytoskeletal regulators to similarly affect
filopodial dynamics and neurite outgrowth. Actin binding proteins such as ADF/cofilin and
annexin might serve as such convergence points, as they have been shown to be regulated by
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Ca2+, phophatidylinositide binding and phosphorylation/dephosphorylation events (Bamburg,
1999; Hayes et al., 2004).

Filopodial length and number can be regulated independently
Interestingly, inhibition of PI-3K and kinases downstream had no significant effects on
another morphological growth cone parameter, filopodial number. In previous studies, we had
described that filopodial elongation was often coupled to a decrease in filopodial number (Van
Wagenen and Rehder, 1999; Cheng et al., 2000). The present study provides strong evidence that
the parameters length and number can be regulated independently from each other. This may be
of significance to a navigating growth cone, which would be able to increase its action radius by
elongating its filopodia without losing spatial resolution through a decrease in the number of
sensors. We observed a similar uncoupling in filopodia length and number after local uncaging
of Ca2+ in growth cones (Cheng et al., 2002), which resulted in a transient elongation of filopodia
for approximate 30 min. in response to an increase in intracellular Ca2+ lasting several seconds.

CONCLUSIONS
Taken together, our results demonstrate that signaling events leading to the inhibition of PI-3K
resulted in an increase in filopodial length and a decrease in neurite outgrowth, and as such could act
as a signal for a slow-down and search behavior (Fig. 2.11). Inhibition of key kinases located
downstream of PI-3K activity also resulted in filopodial elongation (ROCK, Akt, and MEK) and in a
decrease in neurite advance (ROCK and Akt), consistent with the notion that PI-3K might act
through these kinases to affect growth cone motility. In extension, other signaling pathways
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Figure 2.11: Model of regulation of neurite outgrowth and filopodial motility by PI-3K.
(A) Baseline PI-3K activity leads to downstream signaling events that result in growth cones
advancing with ‘baseline’ speed and having filopodia of certain lengths. (B) When PI-3K or key
kinases in the proposed pathway downstream of PI-3K are inhibited or otherwise reduced in their
activity, growth cones undergo a “slow-down and search” behavior, characterized by filopodial
elongation and a concomitant decrease in the rate of neurite advance. Note that depending upon the
duration or intensity with which a pathway is inhibited, the growth cone may respond with either the
combined slow down and search behavior or with filopodial elongation (“search”) alone.
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converging on these kinases are expected to have predictable effects on neurite outgrowth and
filopodial behavior. Filopodial elongation in response to PI-3K inhibition was shown to result
largely from an increase in actin polymerization, and not from an inhibition of the retrograde flow.
The detailed pathways that link the activity of these kinases to changes in the growth cone
cytoskeleton will have to be investigated in future studies.
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Chapter 3 : Nitric Oxide Release from a Single Cell Affects Filopodial Motility on Growth
Cones of Neighboring Neurons
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Abstract
Nitric oxide (NO), a gaseous messenger, has been reported to be involved in a variety of
functions in the nervous system, ranging from neuronal pathfinding to learning and memory. We
have shown previously that the application of NO via NO donors to growth cones of identified
Helisoma buccal neurons B5 in vitro induces an increase in filopodial length, a decrease in
filopodial number, and a slowing in neurite advance. It is unclear, however, whether NO released
from a physiological source would affect growth cone dynamics. Here we used cell bodies of
identified neurons known to express the NO synthesizing enzyme nitric oxide synthase (NOS) as
a source of constitutive NO production and tested their effect on growth cones of other cells in a
sender-receiver paradigm. We showed that B5 cell bodies induced a rapid increase in filopodial
length in NO-responsive growth cones, and that this effect was blocked by the NOS inhibitor 7NI, suggesting that the effect was mediated by NO. Inhibition of soluble guanylyl cyclase (sGC)
with ODQ blocked filopodial elongation induced by B5 somata, confirming that NO acted via
sGC. We also demonstrate that the effect of NO was reversible and that a cell releasing NO can
affect growth cones over a distance of at least 100 µm. Our results suggest that NO released from
a physiological source can affect the motility of nearby growth cones and thus should be
considered a signaling molecule with the potential to affect the outcome of neuronal pathfinding
in vivo.

Introduction
Nitric oxide (NO), a gaseous messenger, has been described to play an important role
during neuronal development, such as in the formation of retinal projections in vivo (Williams et
al., 1994; Cramer et al., 1996; Gibbs and Truman, 1998; Cramer and Sur, 1999; Ernst et al.,
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1999; Wildemann and Bicker, 1999; Wu et al., 2000), but also in neuronal differentiation and
neurite outgrowth in general (Hess et al., 1993; Peunova and Enikolopov, 1995; Hindley et al.,
1997; Poluha et al., 1997; Nakaya et al., 2000; Rialas et al., 2000; Gallo et al., 2002). During the
development of the grasshopper embryo, NO, potentially released from epithelial cells facing the
basal lamina of the developing antenna, has been shown to regulate axonal pathfinding of
antennal pioneer neurons (Seidel and Bicker, 2000; Bicker, 2007). We have shown previously
that NO donors applied to identified Helisoma B5 neurons grown in vitro induce an increase in
filopodial length and a concomitant decrease in neurite outgrowth (Van Wagenen and Rehder,
1999; Trimm and Rehder, 2004; Welshhans and Rehder, 2005), suggesting that some of the
developmental effects of NO described in the literature might result from NO acting on neuronal
growth cones. A follow up study, in which NO donors were applied focally to B5 growth cones,
indeed confirmed that NO regulates filopodial motility locally at the growth cone and that the
NO signaling pathway included soluble guanylyl cyclase (sGC), protein kinase G (PKG), cyclic
adenosine diphosphate ribose (cADPR) and intracellular calcium release from ryanodine
sensitive stores (Welshhans and Rehder, 2005; Welshhans and Rehder, in press). While the
application of NO donors has proven to be a practical approach to test effects of NO in numerous
preparations, it is not known whether NO released physiologically from other cells would affect
growth cone motility as well. It has been shown both in vivo and in vitro that cellular release of
NO can have measurable effects on neighboring cells, such as acting as a modulator of neuronal
excitability (Elphick et al., 1995; Park et al., 1998).
The ultimate determination whether cellular release of NO can affect growth cone motility in
another cell by acting in a paracrine fashion has not yet been made. In this study we used cell bodies
of identified neurons known to express the NO synthesizing enzyme nitric oxide synthase (NOS) as
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sources of constitutive NO production and paired them with growth cones to be tested for their
response to NO. To facilitate the testing, neuronal somata adhering to a poly-L-lysine coated
microelectrode were maneuvered into the vicinity of growth cones (distances ranging from 20-150
µm) and filopodial dynamics were recorded before and at defined times after stimulation. We here,
to our knowledge for the first time, demonstrate that neuronally released NO is effective in altering
filopodial motility on growth cones of neighboring neurons. This finding not only suggests a role for
NO in neuronal pathfinding, but also provides a straightforward physiological paradigm to study the
effects of NO on cell motility in general.

Methods and Materials
Neuronal culture and image acquisition
Identified B5 and B19 neurons were dissected from Helisoma trivolvis buccal ganglia and plated
for neuronal culture. Neurons to be investigated for the effect of NO on growth cone morphology
(referred to as “Receivers”) were plated on poly-L-lysine (hydrobromide, MW 70,000-150,000,
0.25mg/ml, Sigma, St. Louis, MO) coated glass coverslips glued to the bottoms of a 35 mm cell
culture dishes (Falcon 1008). These cells were grown overnight at room temperature and used
24-48 hours after plating (Fig. 3.1A). Cells used as sources of NO (referred to as “Senders”)
were obtained by placing freshly harvested cell bodies into hemolymph-coated glass dishes
according to Spencer et al. (2000) to prevent them from adhering to the substrate. These cells
were kept at room temperature and used within 24 hours after plating (Fig. 3.1A). “Receiver”
cells were plated into conditioned medium (CM), prepared by incubating snail brains in modified
Leibowitz L-15 medium (Gibco, Grand Island, NY) for 3-4 days. L-15 medium was prepared to
contain final concentration of: 40 mM NaCl, 1.7 mM KCl, 1.5 mM MgCl2, 4.1 mM CaCl2, 10
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Figure 3.1: Schematic of the experimental design.
(A) Sender dishes (coated with hemolymph) contain neuronal cell bodies to be used as NO
“senders”, whereas receiver dishes are coated with poly-L-lysine and contain conditioned medium to
support neurite outgrowth from neurons to be tested in the sender/receiver paradigm. Senders are
transferred to the receiver dish with a fire-polished micropipette. (B) Sender neurons are attached to
a poly-L-lysine coated glass micropipette which is subsequently positioned by a motorized
micromanipulator to hold the sender at variable distances, ranging from 20-150 µm from a
“receiver” growth cone.
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mM HEPES, 50 µg/ml gentamycin, 0.15 mg/ml glutamate in distilled water (pH=7.3) (Cohan et
al., 2003). A fire-polished micropipette, connected hydraulically via plastic tubing to a
micrometer syringe (Gilmont Instruments), was used to transfer an individual “Sender” cell body
into the culture dish containing the neuron to be tested. The “sender” cell body was subsequently
maneuvered into the proximity (20-150 µm) of the “receiver” growth cone by using a poly-Llysine-coated microelectrode attached to a micromanipulator (Spencer et al., 2000) (Fig. 3.1B).
Growth cones were viewed under a 100x oil immersion objective on a Sedival (aus Jena,
Germany) microscope. A regular CCD camera (Model: C-72, MIT Dage, Michigan City, IN)
was used to capture images, which were digitized on a frame grabber (Scion LG-3, Scanalytics,
Fairfax, VA) and analyzed with “Scion Image” software (Scion Corporation; Frederick,
Maryland) on a Hewlett-Packard Pavilion (Hewlett-Packard Company, Palo Alto, CA).
Pharmacological agents
7-NI (7-Nitroindazole, nNOS inhibitor) and ODQ (1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one,
soluble guanylyl cyclase inhibitor) were dissolved in dimethylsulfoxide (DMSO, Sigma) to obtain
stock concentrations of 10 and 20 mM respectively. All drugs were purchased from Calbiochem
(San Diego, CA).
Design and analysis of growth cone dynamics
Observation of filopodial length and number were performed at defined times before and
after moving a “sender” cell body into the vicinity of the growth cone to be tested. Other growth
cones on the same cell, but located at considerable distances from the growth cone to be tested,
were used as controls (not stimulated by the sender) and labeled as “Non-receiver growth cone”.
In experiments involving 20 min of preincubation with a pharmacological agent, drugs were
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premixed in 2 mL of L-15 medium to obtain final concentrations, and introduced to the dish by
complete medium exchange. Growth cone dynamics were analyzed during the preincubation
period to determine whether any of the drugs would have an effect by itself. Images were
captured before (-5 and 0 min) and at defined times (2, 5, 10, 15, 20, and 30 minutes) after
maneuvering the sender into the vicinity of the growth cone.
Digitized images of growth cones were analyzed by measuring the length of all
individual filopodia from their tip to the edge of the central domain, preventing potential
incorrect measurement influenced by lamellipodial dynamics. Filopodial length was measured
for each filopodium on a growth cone from phase contrast images using the software package
“Scion Image” and is expressed as mean filopodial length. To compensate for the variability
observed in growth cone size and filopodial length between different growth cones, these values
were expressed as a percentage change normalized to the time point t = 0 just prior to any
manipulation.

Statistical analysis
Analysis of variance (repeated measures ANOVA with time as repeated measures when
appropriate), and t-test for independent samples with SuperANOVA (Abacus Concepts, Berkeley,
CA) were performed to determine statistical significance between conditions. Fisher’s protected least
significant difference (PLSD) test was used as post-hoc analysis of preplanned comparisons.
Significant differences are indicated as: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
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Results
Growth cone dynamics are affected by a B5 sender/receiver paradigm
To investigate if the physiological release of NO from a neuron could act as a messenger and affect
nearby growth cones, we made use of the fact that B5 neurons express NOS (Van Wagenen and
Rehder, 2001), produce NO (Ivanova and Rehder, unpublished results), and can therefore be used as
a physiological source of NO. Other cells, such as the B19 neuron, were previously demonstrated to
not contain significant NOS immunoreactivity and therefore have been used successfully as negative
controls (Van Wagenen and Rehder, 2001). To make the stimulation paradigm as flexible as
possible, we used a poly-L-lysine coated micropipette, which adheres well to any cell body and thus
provides a handle by which a cell body can be moved easily within the dish (Spencer et al., 2000).
Using this approach, cell bodies can be positioned and held at variable distances from growth cones
of other cells growing in the culture dish. The “sender” is subsequently maneuvered into position
close to a growth cone to be tested (referred to as the “receiver”). Stimulation of a B5 receiver
growth cone by a B5 sender positioned at a distance of 20-30 µm resulted in a significant and rapid
elongation of filopodia when compared to the control condition, in which a poly-L-lysine coated
micropipette was positioned at the same distance alone (p ≤ 0.001) (Fig. 3.2A and B). The
elongation started as early as 2 minutes after the sender was moved into place and reached a plateau
of 24.7 ± 2.5% after 10 minutes. Interestingly, the average number of filopodia on a given growth
cone was not affected by the presence of the sender (p = 0.82) (Fig. 3.2C). Importantly, the effect of
the sender was limited to the stimulated growth cone, as stimulation with a B5 sender for 15 minutes
induced a significant increase in filopodial length on B5 receiver growth cones compared to other
growth cones on the same cell that were located further away from the sender (p ≤ 0.001) (Fig.
3.2D). These results, obtained with the sender/receiver paradigm, suggested that B5 neurons
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Figure 3.2: Stimulation of B5 receiver growth cones by B5 senders results in an increase in
filopodial length.
(A) Phase contrast images of a representative B5 receiver growth cone 5 min before (pre) and 10
min after stimulation by a B5 sender. Note strong filopodial elongation elicited by a B5 soma held
approximately 30 µm ahead of the growth cone and located just outside of the image. Scale bar, 10
µm. (B) B5 senders held at a distance of 20-30 µm from the growth cone to be tested caused a
significant increase in filopodial length on B5 receivers as early as 2 min after placement of the
sender and reached a plateau after 10 min when compared to pipette stimulation alone (p ≤ 0.001).
Filopodial length was not affected by the pipette alone. Cell bodies of B19 neurons used as senders
had no effect on filopodial length (p = 0.06). (C) B5 and B19 senders did not cause changes in
filopodial number compared with the pipette treatment alone (p = 0.82 and p = 0.83 respectively).
The pipette alone did not change filopodial number. (D) A 15 min stimulation with a B5 sender
induced a significant increase in filopodial length on B5 receiver growth cones compared to growth
cones on the same cell located farther away from the sender (p ≤ 0.001).
For all experiments the number of growth cones studied per condition is given as ‘n’.
Statistical significance between conditions is symbolized by asterisks as follows: *p ≤ 0.05, **p ≤
0.01, ***p ≤ 0.001.
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release a diffusible factor(s) that can affect filopodial dynamics on B5 growth cones nearby.
To confirm that the effect of the B5 sender was owing to the release of NO and not some
other diffusible factor released by neurons, we next tested the effect of another identified neuron,
B19, which does not express nNOS (Van Wagenen and Rehder, 2001). When B19 cell bodies were
used as the sender and positioned approximately 20 µm from B5 growth cones, filopodial length and
number were not significantly affected (p = 0.06 and p = 0.83 respectively) when compared to the
micropipette alone group, but filopodial length differed significantly from the condition in which a
B5 neuron was used as the sender (p ≤ 0.01) (Fig. 3.2B and C). Not surprisingly, the B19 sender also
had no significant effect on filopodial number (p = 0.99, as compared to B5 senders) (Fig. 3.2C).
To test independently whether the effects of a B5 sender were mediated by NO, B5
sender/receiver pairs were preincubated with the specific nNOS inhibitor 7-NI (10 µM) for 20
minutes before moving the B5 sender into the proximity of the receiver growth cone. Treatment with
7-NI blocked the filopodial elongation normally induced by B5 senders (p ≤ 0.001, Fig. 3.3A), and
had no effect on filopodial number (p = 0.18) (Fig. 3.3A and B). Preincubation with 7-NI by itself
had no effect on filopodial dynamics (Fig. 3.3A and B). Taken together, these results support the
hypothesis that B5 senders affect growth cone morphology of neurons in their vicinity by releasing
NO.

sGC mediates the response of growth cones to NO released by a physiological source
The NO signaling pathway has been shown to act mainly through activation of
soluble guanylyl cyclase (sGC) (Arnold et al., 1977; Ahern et al., 2002), and direct S-nitrosylation of
proteins (Jaffrey et al., 2001). Because we had shown previously that NO donors induce changes
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Figure 3.3: Inhibition of nNOS prevents the B5 sender-induced increase in filopodial
length.
(A) Pretreatment with the nNOS inhibitor 7-Nitroindazole (7-NI) (10 µM) for 20 min abolished the
increase in filopodial length induced by B5 senders (p ≤ 0.001 compared with B5 senders alone). 7NI itself had no effect on filopodial length. (B) Pretreatment with 10 µM 7-NI followed by
stimulation with B5 senders did not change filopodial number (p = 0.18 compared with B5 senders
alone). Filopodial number was not affected by 7-NI itself. Note that the data for the B5 sender from
Fig. 3.1B and C have been added to facilitate comparison.
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in growth cone morphology of B5 neurons through activation of sGC (Van Wagenen and
Rehder, 1999), it was important to confirm that NO released from a physiological source in the
sender/receiver paradigm would act through the same signaling pathway. To this end, B5
sender/receiver pairs were preincubated with the sGC inhibitor ODQ (20 µM) for 20 minutes
before moving the sender into the proximity of the receiver growth cone. Treatment with ODQ
blocked changes in filopodial length normally induced by B5 senders (p ≤ 0.001) (Fig. 3.4A).
Again, filopodial number was not affected by this experiment (p = 0.17) (Fig. 3.4B). The
incubation with ODQ alone did not affect growth cone morphology (Fig. 3.4A and B). These
results are consistent with our previous findings and suggest that the NO released from a
physiological source acts via its canonical target, sGC, to regulate filopodial length.

The effect of NO released from a physiological source is reversible and distance- dependent
Previous studies from our laboratory showed that application of the NO donor SIN-1 to an
entire cell culture dish (global stimulation) induced a rapid increase in filopodial length which
showed a transient peak and a subsequent sustained plateau (Van Wagenen and Rehder, 1999; Van
Wagenen and Rehder, 2001). By contrast, short-term stimulation with the NO donor NOC-7 applied
locally to a growth cone via a micropipette for about 40 ms caused only transient filopodial
elongation (Welshhans and Rehder, 2005), suggesting that the NO effect is dependent on the
duration of the stimulation with NO. This hypothesis was supported further by the findings in this
paper, in which we demonstrate that filopodia remained elongated in the presence of the B5 sender
(Fig. 3.2B). Therefore, we next investigated whether the effect of NO on filopodial length was
reversible. To address that question, B5 senders were maneuvered into the proximity of B5 receivers
(20-30 µm) for 15 minutes, then the senders were subsequently moved away and filopodial
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Figure 3.4: Inhibition of sGC abolishes the B5 sender-induced increase in filopodial length.
(A) Pretreatment with the sGC inhibitor 1H-[1,2,4]Oxadiazolo[4,3-a]quinoxalin-1-one (ODQ)
(20 µM) for 20 min prevented the increase in filopodial length induced by B5 senders (p ≤ 0.001
compared with B5 senders alone). ODQ itself had no effect on filopodial length. (B)
Pretreatment with 20 µM ODQ followed by stimulation with B5 senders did not result in a
change in filopodial number (p = 0.17 compared with B5 senders alone). Filopodial number was
not affected by ODQ itself. Note that the data for the B5 sender from Fig. 3.1B and C has been
added to facilitate comparison.
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length re-assessed one hour later. Whereas filopodial length increased by 28.9 ± 4.7% after 15
minutes of pairing with a B5 sender, subsequent removal of the sender resulted in a significant
decrease in filopodial length toward baseline, reaching 12.5 ± 3.5% above pretreatment levels after 1
hour (p ≤ 0.01) (Fig. 3.5A). It is interesting to note that filopodial length did not return to baseline
even after 2 hours of sender removal (data not shown), suggesting that the exposure to NO had
resulted in a long term change in the receiver growth cone. To test if a growth cone would be
responsive to a second exposure of NO, a B5 sender was brought in again after one hour and
positioned 20 µm away from a receiver growth cone. This second exposure to a sender induced
another significant increase in filopodial length from the previously elevated plateau of 12.5 ± 3.5%
to 34 ± 4.3% after 30 minutes (p ≤ 0.001) (Fig. 3.5A). It is interesting to note that there was no
significant difference between the degree of filopodial elongation induced by the first and second
presentation of the sender (p = 0.283). These results suggested that the effect of NO release from a
physiological source, while being partially reversible, has a long lasting effect on the receiver.
Nevertheless, growth cones were capable of responding with filopodial elongation to a second
exposure to a B5 sender, suggesting that they had maintained their sensitivity to NO.
Next we investigated the distance over which a sender could affect the morphology of a
receiver growth cone. To this end, we systematically increased the distance between the sender and
the receiver. There was no significant difference in the degree of filopodial elongation when a B5
sender was placed at a distance of either 20-30 µm or 60 µm (p = 0.334) from a receiver growth cone
(23.9 ± 2.4% and 26.3 ± 3.4% respectively after 15 minutes (Fig. 3.5B). When the B5 sender was
located at a distance of 100 µm, filopodial elongation was significantly reduced, to 11.9 ± 2.1% (p ≤
0.05 and p ≤ 0.001 compared to 20-30 µm and the control (pipette) respectively) (Fig. 3.5B). When
the distance between sender and receiver was increased further to 150 µm, the sender no longer had
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Figure 3.5: A B5 sender can act over a distance of at least 100 µm and its effect on
filopodial length is partially reversible.
(A) Removal of B5 senders from B5 receiver growth cones for 60 min resulted in a significant
reduction in filopodial length on growth cones stimulated previously by a sender for 15 min (p ≤
0.01). Growth cones remained responsive to NO after sender removal, because moving a sender
back into the proximity of a receiver growth cone for 30 min (also see above) resulted in another
significant increase in filopodial length (p ≤ 0.001). (B) Stimulation with B5 senders held to a
distance of 60 µm induced the same degree of filopodial elongation as senders held at 20-30 µm
(p = 0.334). Senders held at 100 µm induced filopodial elongation (p ≤ 0.001 compared with
pipette), but the elongation was significantly less then the one induced by senders held at 20-30
um (p ≤ 0.05). Senders held at 150 µm had no effect on filopodial length (p = 0.184).
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a measurable effect on the receiver (p = 0.184). This series of experiments suggested that the
effective distance over which NO can have a physiological effect on filopodial dynamics in this in
vitro preparation is at least 100 µm.

Discussion
In the nervous system, nitric oxide has been shown to be involved in numerous processes,
including development, synaptic plasticity, and cell death (Ernst et al., 1999; Lipton, 1999;
Thippeswamy et al., 2001; Contestabile and Ciani, 2004; Regulski et al., 2004; Matarredona et
al., 2005; Bicker, 2007; Hara and Snyder, 2007; McFarland et al., 2007). NO is produced
enzymatically by nitric oxide synthase (NOS), which has 3 isoforms: neuronal (nNOS), inducible
(iNOS) and endothelial (eNOS) (Garthwaite, 1991). NO is known to act by several mechanisms,
including the activation of the enzyme soluble guanylyl cyclase (sGC) by the binding of NO to
its heme moiety (Dierks and Burstyn, 1996), nitrosylation of cysteine residues in proteins to
produce S-Nitrosothiols (Arnold et al., 1977; Stamler et al., 1992; Jaffrey et al., 2001; Ahern et
al., 2002), and nitration of tyrosine residues (Ischiropoulos, 1998). In addition to its effect on
protein regulation, NO can also act on DNA (Wink et al., 1991).
During nervous system development and regeneration, neuronal pathfinding describes the
process by which growth cones navigate to their targets, using diffusible and membrane bound
cues encountered along the way. There are many guidance cues, such as netrins, semaphorins,
ephrins and cell adhesion molecules, which are known to signal to the passing growth cone and
potentially affect the speed and direction of growth cone advance (Tessier-Lavigne and
Goodman, 1996; Dickson, 2002; Chilton, 2006), however the potential of the gaseous messenger
NO to affect neuronal pathfinding and cell motility is only beginning to be explored. Early
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studies used various NO donors to test the effect of NO on growth cone motility, neurite
outgrowth and neurite initiation (Hindley et al., 1997; Van Wagenen and Rehder, 1999; Rialas et
al., 2000; Gallo et al., 2002; Gendron et al., 2002; Trimm and Rehder, 2004; Zhang et al., 2005;
Yamada et al., 2006). We have shown previously that global application of nitric oxide (NO)
with NO donors can induce changes in both growth cone dynamics and neurite outgrowth in an
identified neuron from the buccal ganglion of the mollusk Helisoma trivolvis. In the B5 neuron,
NO induces an increase in filopodial length, a decrease in filopodial number and a decrease in
neurite outgrowth (Van Wagenen and Rehder, 1999; Trimm and Rehder, 2004). Moreover, we
have demonstrated that the increase in filopodial length is accomplished by an increase in both
the velocity with which filopodia extend and the time they spend extending (Van Wagenen et al.,
1999). The reduction in the number of filopodia could be explained by a decrease in the rate with
which new filopodia are inserted into the lamellipodial veil to make up for those filopodia being
reabsorbed. In addition we have shown that NO induces the same changes in growth cone
morphology when it is applied locally and only for a brief time to a single growth cone, a
stimulus that potentially more closely mimics a physiological condition (Welshhans and Rehder,
2005).
Whereas the NO donors used in the experiments described above have different half
times of release, which make them useful tools for testing effects of NO, a more physiologically
relevant description of the effects of NO on the nervous system will have to include experiments
in which the effects of cellular release of NO on cellular targets are studied. Studies in the
grasshopper reported a role for NO in regulating neuronal migration in the enteric nervous
system and axonal pathfinding of pioneer neurons in the antenna (Seidel and Bicker, 2000;
Haase and Bicker, 2003; Bicker, 2007). While these studies clearly demonstrate that cell
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migration is controlled by cells releasing NO along the path of migratory cells, a direct effect of
cellular NO release on growth cone motility has yet to be demonstrated.
Here we use a sender/receiver paradigm to study the effect of cellular NO release on
growth cone motility. A cell that releases NO constitutively is used as the physiological NO
source and functions as the sender which can be moved easily to any location within the dish.
This approach is more convenient than plating two cells close to each other, in the hopes that
their processes will grow towards each other. While the latter approach makes it difficult to
control for the exact distance between sender and receiver, the movable sender paradigm
increases the experimenter’s control over the experimental design.

NO released from a physiological source affects growth cone dynamics via sGC
Stimulation of B5 receiver growth cones by B5 sender cell bodies induced a strong and
rapid increase in filopodial length (Fig. 3.2A and B). Interestingly this effect on filopodial
dynamics was abolished by inhibition of NOS with the specific NOS inhibitor 7-NI (10 µM).
Moreover, stimulation with B19 neurons (Fig. 3.2B), which were shown previously to contain
little or no NOS immunoreactivity (Van Wagenen and Rehder 2001) had no effect on filopodia
of B5 receivers, further supporting the hypothesis that filopodial elongation was NO-dependent.
Other examples of an effect of neuronal NO release on neighboring cells exist, suggesting that
release from one cell can affect the physiology of a neighboring cell. For example, electrical
stimulation of B2 neurons in another mollusk, Lymnaea stagnalis, induces depolarization of
B7nor neurons via signaling by NO in both the intact central nervous system and in cell culture
(Park et al., 1998). In the hippocampus, evidence has been provided for NO to act as the elusive
retrograde messenger in synaptic plasticity, namely long-term potentiation (Bohme et al., 1991;
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O'Dell et al., 1991; Schuman and Madison, 1991; Bon and Garthwaite, 2001; Bon and
Garthwaite, 2003; Hopper and Garthwaite, 2006). There is a convincing literature that
neurotransmitters can affect neurite outgrowth (McCobb et al., 1988; Lipton and Kater, 1989;
Spencer et al., 2000; van Kesteren and Spencer, 2003; Fricker et al., 2005; Homma et al., 2006;
Ryan et al., 2007), and a sender/receiver paradigm similar to the one used in our study was
employed with Lymnaea neurons to demonstrate that dopamine can affect growth cone motility.
In this study, dopamine released from the right pedal dorsal 1 (RPeD1) neuron was shown to
regulate growth cone behavior of target and non-target neurons differentially (Spencer et al.,
2000). Here we demonstrate that NO, released by a single cell, can have a strong effect on
growth cones in its vicinity but not on growth cones located further away, clearly demonstrating
that NO has the potential to affect neurite outgrowth locally. Our results also confirm earlier
reports on the same cell type that demonstrated that NO brought about its effect on growth cone
morphology and advance via activation of sGC (Van Wagenen and Rehder, 1999; Trimm and
Rehder, 2004), as the effect of the sender on growth dynamics of the receiver was blocked in the
presence of the sGC inhibitor ODQ (Fig. 3.4).

The effect of cellular NO release on filopodial dynamics is reversible and dose dependent
Whereas previous studies in vivo have demonstrated effects of NO on cell motility and
neurite outgrowth (Gibbs and Truman, 1998; Chen et al., 2000; Seidel and Bicker, 2000; Haase
and Bicker, 2003; Bicker, 2005), these experiments were mainly based on pharmacology to
inhibit NO signaling and their conclusions were, therefore, somewhat indirect. Our results
suggest that B5 neurons produce NO constitutively and that a growth cone entering the “plume”
of NO created by such a sender cell would respond by elongating its filopodia. This is the first
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report in which the effects of NO released from a single cell have been measured using growth
cone motility as a sensitive bioassay. Our results clearly demonstrate that a single, unstimulated
cell body can release enough NO to affect an advancing growth cone. Because NOS, in the case
of the B5 neuron, is expressed throughout the entire neuron, we envision that even growth cones
of B5 neurons can release NO, possibly affecting other cells in their vicinity. Clearly, the B5
neuron may be unique in that it produces NO and also responds to it. As such, it could serve as a
source of NO for its own purposes as well as supplying NO to the larger environment. We have
shown previously that B5 neurons are responsive to the NO they produce constitutively, as
neurite outgrowth slowed when either NOS or sGC was inhibited, suggesting that intrinsically
produced NO plays a role in determining the speed of neurite advance (Trimm and Rehder,
2004). It is reasonable to assume that other cells in the snail CNS will show a more conventional
separation between NO producing and sGC expressing cells, making NO a paracrine modulator.
Because the NOS enzyme is activated via Ca/calmodulin, it is likely that the amount of NO
being produced and released by a B5 neuron will depend on the intracellular calcium
concentration, and would thus be modulated by neuronal activity. Future studies will investigate
the relationship of cellular electrical activity and NO release.
Interestingly, the effect of NO release on filopodial length was reversible, as filopodia
shortened again after the NO sender was removed, but the reversibility was incomplete,
indicating that some long-term changes in the state of the growth cone had resulted from a 15
minute exposure to NO. Additionally, it is expected that any effect of NO would be dose
dependent. Modeling studies of NO release, taking into account the half life and diffusion of NO
from a point source, suggest that NO might have physiological effects in a 200 µm diameter
sphere (Lancaster, 1994; Wood and Garthwaite, 1994; Lancaster, 1997), but the action radius of
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NO will clearly depend on the dynamics of NO production, its decay, and the general cellular
environment. Our result show clearly that the effect of NO varied inversely with the distance
between the sender and the receiver growth cone. While maximal effect was seen between 20-60
µm, NO still affected growth cones that were located 100 µm away, but failed to elicit an effect
at 150 µm. These results fall nicely into the range of effective distances as reported above. It
should be kept in mind, however, that our experiments were performed on single cells in vitro,
and that the NO radius of action in the intact nervous system might well be different.
NO released from tissues and cells within tissues has been detected by NO electrodes
(Friedemann et al., 1996; Bedioui et al., 1997) and the use of fluorescent dyes, such as DAF-2A
(Kojima et al., 1998), but a quantification of the amount of NO released from single cells is not
trivial. Recently, Patel et al. (2006) reported that NO released from single neurons in the isolated
CNS of Lymnaea stagnalis was detected by multiple film-coated electrode sensors. A cell-based
indicator, called Picell, detected picomolar concentrations of NO released from single
endothelial cells and hippocampal neurons in culture (Sato et al., 2006). These tools will be
important in future investigations to directly measure the spatio-temporal NO release from B5
senders.

A role for NO in neuronal pathfinding and synaptogenesis
Neuronal pathfinding takes place on the background of a rapidly changing nervous
system, both molecularly and structurally. Well orchestrated expression of guidance cues and
their cellular receptors play an important part in guiding an axon towards its target and assist in
synaptogenesis (Martinez et al., 1998; Kaprielian et al., 2001; Martinez et al., 2005; Dickson and
Gilestro, 2006; Mendes et al., 2006). We do not know for our system whether NOS or the
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presence of its cellular target sGC is developmentally regulated. Studies in the snail Ilyanassa
obsoleta reported an upregulation of NOS in the developing nervous system during the larval
stage, followed by a down regulation through metamorphosis (Lin and Leise, 1996;
Thavaradhara and Leise, 2001). The developmental regulation of both NOS and sGC in the
enteric nervous system of the locust serve as a impressive example of how differential expression
may be useful in establishing the early migratory outcome of cells along the midgut (Haase and
Bicker, 2003; Bicker, 2005; Bicker, 2007).
We have presented data that demonstrate that NO donors applied to neurons grown in cell
culture can affect growth cone motility and it is reasonable to assume that NO might influence
neuronal pathfinding in vivo. Our observation that NO resulted in filopodial elongation and a
slow-down in growth cone advance, a response we termed ‘slow down and search’ behavior,
could indicate a role for NO as a stop signal in the target region prior to synaptogenesis. NOS
has been localized in target regions in several systems and its expression correlated with
synaptogenesis (Roskams et al., 1994; Williams et al., 1994; Ogilvie et al., 1995). Recent studies
reported that presynaptic plasticity induced during activity-dependent synaptogenesis was
regulated by NO (Nikonenko et al., 2003; Zhang et al., 2005). Moreover, there is evidence that
NO regulates the activity dependent refinement of retinal projections. Inhibition of nNOS by
pharmacological blockers was shown to prevent the elimination of transient ipsilateral
retinotectal projections in the chick visual system, and to affect retinogeniculate projection
patterns in ferret (Wu et al., 1994; Cramer and Sur, 1999).
In conclusion, we have demonstrated that spontaneous NO release from a single neuron
has physiological effects on the dynamics of growth cones growing in its vicinity, and that this
effect is mediated through the canonical target of NO, namely sGC. These results strongly
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suggest a potential role for NO as a modulator of growth cone motility during neuronal
pathfinding and synaptogenesis in vivo.
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Chapter 4 : Research Published in Collaboration: PLA2 and Secondary Metabolites of
Arachidonic Acid Control Filopodial Behavior in Neuronal Growth Cones
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Abstract
The neuronal growth cone provides the sensory and motor structure that guides neuronal
processes to their target. The ability of a growth cone to navigate correctly depends on its
filopodia, which sample the environment by continually extending and retracting as the growth
cone advances.

Several second messengers systems that are activated upon contact with

extracellular cues have been reported to affect growth cone morphology by changing the length
and the number of filopodia. Because recent studies have suggested that guidance cues can
signal via G-protein coupled receptors to regulate phospholipases, we here investigated whether
phospholipase A2 (PLA2) may control filopodial dynamics and could thereby affect neuronal
pathfinding. Employing identified Helisoma neurons in vitro we demonstrate that inhibition of
PLA2 with 2

M BPB caused a 40.3% increase in average filopodial length, as well as a 37.3%

reduction in the number of filopodia on a growth cone. The effect of PLA2 inhibition on
filopodial length was mimicked by the inhibition of G-proteins with 500 ng/ml pertussis toxin
and was partially blocked by the simultaneous activation of PLA2 with 50nM melittin. We
provide evidence that PLA2 acts via production of arachidonic acid (AA), because (a) the effect
of inhibition of PLA2 could be counteracted by supplying AA exogenously, and (b) the inhibition
of cyclooxygenase, which metabolizes AA into prostaglandins also increased filopodial length.
We conclude that filopodial contact with extracellular signals that alter the activity of PLA2 can
control growth cone morphology and may affect neuronal pathfinding by regulating the sensory
radius of navigating growth cones.
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Introduction
Phospholipase A2 (PLA2) is a group of enzymes that catalyze the breakdown of
phospholipids. They are activated by signaling through calcium (van den Bosch, 1980), kinases
(Lin et al., 1993), growth factors (Spaargaren et al., 1992), or through metabotropic receptors,
such as glutamate receptors (Dumuis et al., 1993). The mechanism by which G-proteins activate
PLA2 is unclear, as activation has been reported to occur through an unknown G-protein
(Tsunoda and Owyang, 1994) or the activity of Gi (Dickerson and Weiss, 1995). While PLA2
plays a role in membrane maintenance and breakdown (Bonventre, 1992), it also produces a
number of active messengers with wide ranging cellular functions (Axelrod, 1990). PLA2 cleaves
phospholipids, thereby producing arachidonic acid (AA) and lysophospholipids (Negre-Aminou
and Pfenninger, 1993). Messengers produced by PLA2 activity have been demonstrated to affect
neurite advance, as inhibition of PLA2 decreases outgrowth in dorsal root ganglion neurons from
the adult frog (Edstrom et al., 1996) and mouse (Hornfelt et al., 1999). In addition, PLA2 is
localized to rat nerve growth cones (Negre-Aminou et al., 1996) and is necessary for growth
cone formation (Geddis and Rehder, 2003). Finally, PLA2 is involved in thrombin-induced (de
La Houssaye et al., 1999) and semaphorin 3A-induced (Mikule et al., 2002) growth cone
collapse. Taken together, the involvement of PLA2 in neurite outgrowth and its localization to the
growth cone suggest that it may play an important role in generating growth cone behavior.
In the developing nervous system, neuronal growth cones navigate through a complex
environment in order to make appropriate synaptic connections. Filopodia have been shown to be
of critical importance in this process, as growth cones stripped of their filopodia are impaired in
their pathfinding abilities (Bentley and Toroian-Raymond, 1986). Receptors on filopodia contact
cues ahead of the growth cone proper, and the ability of filopodia to undergo length changes
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provides a growth cone with the capability to adjust its action radius according to the particular
pathfinding situation. The detection of extracellular cues by receptors on filopodia is thought to
activate intracellular signals that control growth cone behavior such as growth cone advance
(Nakamura et al., 2000) and steering (O'Connor et al., 1990). It has been reported previously that
intracellular signaling molecules such as phosphatases, kinases and calcium are involved in
controlling growth cone behavior in identified Helisoma neurons (Davenport and Kater, 1992;
Rehder and Kater, 1992; Welnhofer et al., 1999). Whereas our knowledge of the signaling
mechanisms downstream of extracellular ligands such as semaphorins, netrins and certain growth
factors (such as EGF and NGF) is increasing rapidly (Handler et al., 1990; Weisenhorn et al.,
1999; Segal, 2003), we know very little about the potential role of lipid-derived messengers in
regulating growth cone behavior.
Given the central role played by filopodia in growth cone navigation, this study
investigates mechanisms by which phospholipase A2-mediated second messengers control
filopodial dynamics. A pharmacological approach is employed to demonstrate that PLA2 activity
regulates filopodial length and number through the production of arachidonic acid and two of its
products, prostaglandins and leukotrienes. Therefore, guidance cues which signal through PLA2
should be considered as potential candidates to direct the outcome of neuronal pathfinding.

Methods and Materials
Neuronal culture and imaging
Identified B5 neurons were dissected from Helisoma trivolvis buccal ganglia and plated
for neuronal culture. Neurons were plated onto a poly-L-lysine-(hydrobromide, MW 70,000150,000, 0.25 mg/ml, Sigma, St. Louis, MO) coated glass coverslip glued to the bottom of a 35
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mm cell culture dish. Cells were allowed to grow overnight at room temperature and used 24-48
hours after plating. Cells were grown in conditioned medium prepared by incubating snail brains
in Leibowitz L-15 medium (special order, Gibco, Grand Island, NY) modified to a final
concentration of: 40 mM NaCl, 1.7 mM KCl, 1.5 mM MgCl2, 4.1 mM CaCl2, 10 mM HEPES,
50

g gentamycin/ml, 0.15 mg glutamate/ml in distilled water (pH = 7.3). Growth cones were

viewed under a 100x oil immersion objective on an Axiovert (Carl Zeiss, Thronwood, NY) or a
Sedival (aus Jena, Germany) microscope. Images were captured with a cooled CCD (CH250,
Photometrics, Tucson AZ) or C-72 camera (MIT Dage, Michigan City, IN) interfaced with NIH
image software (Wayne Rasband, NIH). The images were viewed and analyzed on a Power
Macintosh (Apple Computer, Cupertino, CA).

Pharmacological treatments
Observation of growth cone behavior, specifically changes in filopodial length and number,
was performed at defined times before and after the addition of pharmacological agents, which
were added through a complete medium exchange. Images were captured before (-5 and 0 min)
and at defined times after (2, 5, 10, 15, 20, 30 minutes) a complete medium exchange, which
introduced the experimental condition. A complete medium exchange was accomplished by
removing all medium from the dish, except from the center well formed by the coverslip attached
to the dish (approximate volume: 200 µl), and by adding 2 ml of L-15 medium containing the
premixed drug. The phospholipase 2A (PLA2) inhibitors, 4-bromophenacyl-bromide (BPB) was
obtained from Sigma and dissolved to stock concentrations of 2.5 mM in warm methanol. All
other drugs were purchased from Calbiochem (La Jolla, CA). The cyclooxygenase (COX-2)
inhibitor, diclofenac sodium{2-[(2’,6’-Dichlorophenyl)amino] benzeneacetic Acid, Na}
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was dissolved in water to a stock concentration of 5 mM. Cytochalasin B (Helminthosporium
dematioideum) was dissolved in DMSO to a stock concentration of 4 mM, and arachidonic acid
(porcine liver, sodium salt) was dissolved in water to a stock concentration of 200 mM. Control
experiments were performed by addition of the solvents used for the reconstitution of the
pharmacological agents above.

Data analysis and statistics
Growth cone behavior was assessed by determining the change in filopodial length and
number as previously described (Van Wagenen and Rehder, 1999). By using fiduciary markers
present in the dish, filopodial elongation was measured as active protrusion of filopodial tips and
thus ruled out “apparent” elongation, which can result from lamellipodial retraction. Values are
expressed as mean ± SEM. Significance between conditions was determined by performing an
analysis of variance (1-way ANOVA or ANOVA with time as repeated measure) with
SuperANOVA (Abacus Concepts, Berkeley, CA).

Fisher’s Protected Least Significant

Difference (PLSD) test was used for post-hoc tests of statistical significance.

Significant

differences are indicated as: *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.

Results
Filopodial length is controlled by PLA2 activity through arachidonic acid and its secondary
metabolites
To examine how phospholipase 2A (PLA2) may affect filopodial length, and by
extension, the action radius of a navigating growth cone, the activity of PLA2 was inhibited by
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the addition of the specific PLA2 inhibitor 4-bromophenacyl-bromide (BPB). 2

M BPB

induced an increase in filopodial length (Fig. 4.1). To investigate further the pathway by which
PLA2 mediated its effect on filopodial behavior, we examined first the role of AA, the major
product of PLA2 activity, and then key enzymes metabolizing AA (Fig. 4.2). If PLA2 acted
through AA, then it should be possible to interfere with the effect of PLA2 inhibition by
providing AA through alternative sources. AA can be taken up by cells grown in cell culture
when added to the extracellular medium (Piomelli et al., 1987; Carlson and Levitan, 1990).
Extracellularly applied AA (5 µM) had no significant effect on filopodial length when added by
itself (Fig. 4.2), but it significantly reduced the effect of BPB (2µM) on filopodial length when
BPB was applied after cells had been preincubated with AA (5µM) for 5 minutes (p < 0.05),
supporting the hypothesis that PLA2 acted via AA. AA is the substrate of two enzymes that
produce different eicosanoid messengers (Funk, 2001). AA is converted into leukotrienes by the
action of lipoxygenase and into prostaglandins by cyclooxygenase (Fig. 4.2). If PLA2 acted
through one of these pathways, inhibition of these pathways should mimic the inhibition of PLA2
itself. Indeed, inhibition of cyclooxygenase with diclofenac sodium (100

M) caused filopodial

elongation (Fig. 4.3B). Quantification of this effect showed that filopodial length was elevated
by 28.3 ± 3.1% as early as five minutes after cyclooxygenase inhibition.

PLA2 and cyclooxygenase affect filopodial dynamics
Because filopodia are composed of bundled f-actin (Gordon-Weeks, 1987), and filopodial
length changes are to a large part dependent on actin polymerization and depolymerization
events, we started to investigate whether PLA2 inhibition might affect actin dynamics and
thereby lead to filopodial elongation. To address the question whether filopodial elongation was

114
Figure 4.1: The effect of inhibition of PLA2 on filopodial behavior is mediated through
arachidonic acid.
Inhibition of PLA2 with BPB (2 µM) elicited filopodial elongation of 28.6 ± 4.3% five minutes
after treatment, and this effect was significantly blocked to 15.6 ± 3.5% when neurons were
pretreated for 5 minutes with 5 µM AA added to the medium (p < 0.05). The same concentration
of AA added alone had no significant effect on filopodial length.
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Figure 4.2: Mechanisms of PLA2 activation and pathways downstream of PLA2 involved in
controlling filopodial dynamics.
Activation of PLA2 can occur through G-protein coupled receptors or an increase in [Ca2+]i.
PLA2 cleaves phospholipids to produce arachidonic acid (AA) which, in turn, is converted into
prostaglandins and leukotrienes by cyclooxygenase and lipoxygenase, respectively. Inhibition of
PLA2 resulted in distinct changes in growth cone behavior, namely filopodial elongation and a
reduction in the number of filopodia. AA and its secondary metabolites control filopodial
dynamics through the action of leukotrienes and prostaglandins. The mechanisms by which
leukotrienes and prostaglandins affect filopodial dynamics is presently unknown and symbolized
by a black box.
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Figure 4.3: Filopodial elongation resulting from inhibition of PLA2 and cyclooxygenase
involves actin polymerization.
(A) The effect of filopodial elongation observed after 5 minutes of inhibition of PLA2 with BPB
(2 µM) was completely blocked when growth cones were preincubated for 10 minutes with 30
nM cytochalasin B (Cyto B, p ≤ 0.001). The same concentration of cyto B added alone had no
effect on filopodial length. (B) Inhibition of cyclooxygenase with diclofenac Na+ (100 µM)
resulted in an increase in average filopodial length to 28.3 ± 3.1% after 5 minutes of treatment.
This effect was significantly blocked to 5.1 ± 3.6% when growth cones were preincubated with
30 nM cyto B for 10 minutes (p ≤ 0.001) before the addition of diclofenac Na+ (100 µM).
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the result of actin polymerization, growth cones were incubated in cytochalasin B (cyto B, 30
nM) for 10 minutes before adding BPB (2µM). Cytochalasin inhibits actin monomer addition
to the plus end of microfilaments and at this low concentration had no effect on filopodial length
(Fig. 4.3A). When BPB was added in the presence of cyto B, however, the effect of BPB was
completely inhibited (p ≤0.001), suggesting that the BPB-induced filopodial elongation resulted
from actin polymerization. We next investigated if the elongation observed upon inhibition of
cyclooxygenase with diclofenac sodium was also due to actin polymerization. Whereas
diclofenac sodium had its maximal elongation effect as early as 2 minutes after addition, this
effect was completely blocked when the drug was added after growth cones had been incubated
in cyto B for 10 minutes (p ≤ 0.001; Fig. 4.3B).

Discussion
Growth cones are guided by receptors that interact with various guidance cues (TessierLavigne and Goodman, 1996). Ligand-receptor interactions activate particular second messenger
systems that cause directed changes in the growth cone’s cytoskeleton (Gallo and Letourneau,
2000), which ultimately translate into growth cone steering events. Although there is a
considerable body of knowledge describing the role of kinases on growth cone behavior (Jian et
al., 1994; Bonsall and Rehder, 1999; Cheng et al., 2000) and neuronal guidance (Jian et al.,
1994; Burden-Gulley et al., 1997; O'Leary and Wilkinson, 1999; Wills et al., 2002), we know
very little about the potential role of lipid-derived messengers in regulating growth cone
behavior. Lipid-derived messengers can be activated by extracellular ligands through various Gprotein-coupled receptors (Rozengurt, 1991; Roberts, 1996; Funk, 2001), but their effects on
growth cone motility and subsequent neuronal pathfinding have not been well studied. We here
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describe the effects of a prominent class of phospholipases, PLA2, on the regulation of growth
cone filopodia. The data presented suggest that the activity of PLA2 and its downstream products
affect growth cone behavior and could function in the signal transduction cascade from
extracellular guidance cues to the actin-based cytoskeleton.

Inhibition of PLA2 causes filopodial elongation and a reduction in filopodial number
In the presence of the PLA2 inhibitor BPB, the mean filopodial length on growth cones
increased rapidly and filopodia remained elongated for at least 30 minutes. The long-term effects
on filopodia seen with PLA2 inhibition may be due to the fact that BPB is known to bind PLA2
irreversibly (Roberts et al., 1977). Under physiological circumstances, a transient inhibition of
PLA2 activity would be expected to cause short-term filopodial elongation. Such a response
would result in a rapid and transient increase in the action radius of a growth cone and allow it to
survey a larger area during pathfinding.
Filopodia contain bundled f-actin and theoretically, filopodial length can be controlled by
actin polymerization and depolymerization rates, as well as by altering the rate of retrograde
actin flow. The experiments in which actin polymerization was inhibited by cytochalasin
suggested that filopodial elongation observed under PLA2 inhibition resulted from actin
polymerization. After approximately 10 minutes of PLA2 inhibition, filopodia stopped
elongating. This second, longer-term effect of PLA2 inhibition, at which filopodia appeared
somewhat “frozen”, suggested that eventually the mechanism(s) that result(s) in further
filopodial elongation were both inhibited. Our results are consistent with the interpretation that
PLA2 activity is necessary for both filopodial extension and retraction to occur. The notion that
PLA2 activity might be required for actin depolymerization is supported by the result that PLA2
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is necessary for thrombin-induced growth cone collapse (de La Houssaye et al., 1999). Because
our experimental approach did not allow us to differentiate fully between effects of PLA2 on
retrograde flow, or on the barbed and pointed ends of f-actin, future studies will be needed to
determine which of these mechanisms, or which combination of mechanisms, is responsible for
the filopodial elongation observed in these experiments.

Inhibiting the production of AA and its secondary metabolites alters actin dynamics
Our finding that the extracellular addition of AA was able to decrease the effect of PLA2
inhibition and partially blocked filopodial elongation, suggested that PLA2 indeed acted through
AA. AA has been shown to be taken up by cells (Carlson and Levitan, 1990; Piomelli et al.,
1987) and it has to be assumed that the external application of AA increased the intracellular
[AA] such that the inhibition of PLA2, resulting in a reduction of AA production from
phospholipids, had a lesser effect on the overall concentration of AA in the cell. Our attempts to
fully block the effect of PLA2 inhibition by providing extracellular AA was unsuccessful,
because higher concentrations of AA applied externally caused filopodial lengthening itself (data
not shown), potentially due to its effect of raising [Ca2+]i as has been demonstrated for AA in
other cell types (Williams et al., 1994; Roudbaraki et al., 1995).
It has been reported that the products of cyclooxygenase and lipoxygenase activity,
prostaglandins and leukotrienes, work to control actin dynamics. For example, in fibroblasts,
cyclooxygenase inhibitors increase actin polymerization, whereas lipoxygenase inhibitors are
reported to decrease actin polymerization (Peppelenbosch et al., 1993). The former effect is
consistent with our results in which the inhibition of prostaglandin production induced filopodial
elongation. As suggested by its blockage in the presence of cytochalasin, this filopodial
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elongation resulted from actin polymerization and suggested that PLA2 could control actin
dynamics via AA production in Helisoma neurons as well. Therefore, the role of PLA2 in
mediating growth cone behavior may be to produce AA that is further metabolized into
leukotrienes and prostaglandins, which in turn potentiate the cell’s ability to extend and retract
its filopodia through actin polymerization/ depolymerization events.

A role for phospholipases in neuronal pathfinding?
Elucidation of the signaling pathways involved in controlling filopodial dynamics will lead to
a better understanding of how neuronal growth cones traverse the terrains encountered during
pathfinding. In this study we have used a pharmacological approach to demonstrate that the
PLA2 signaling pathway in growth cones affects filopodial behavior by altering filopodial length.
To our knowledge, this study is the first to implicate PLA2 and the secondary metabolites of AA
in the process of filopodial regulation. Whereas the effects described here occurred on a time
scale of minutes, taken together with findings by others that PLA2 inhibition reduces the rate of
neurite outgrowth on a longer time scale, a picture emerges that PLA2 inhibition may signal the
transformation of a growing growth cone into one that extends its filopodia and then slows down
to initiate a searching behavior, as is seen in growth cones that undergo pathfinding decision in
vivo. We restricted our pharmacological experiments to 30 minutes, because we assume that
signaling events mediated through the activation or inhibition of second messenger pathways are
likely to be most effective when they are of short duration, and because effects arising from long
term stimulation are inherently more difficult to interpret. Taken together, we propose that PLA2
may be activated by G-protein coupled receptors or by Ca2+ to produce AA. AA is then
metabolized into leukotrienes and prostaglandins, which act to alter the polymerization and
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depolymerization state of actin (Fig. 4.1). Future studies of guidance cues and their activation of
phospholipases, such as PLA2, in migrating growth cones should shed light on the physiological
role of PLA2 in neuronal pathfinding, as well as further clarify the signaling mechanisms that
regulate the underlying actin dynamics.
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Chapter 5 : General Discussion and Conclusions
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During neuronal pathfinding, growth cones located at the tip of axons and dendrites
encounter and respond to diffusible and membrane-bound cues along the path toward their
targets. These extracellular cues trigger intracellular mechanisms regulating growth cone
cytoskeletal dynamics that are important for correct pathfinding and successful synaptogenesis.
Although many molecules and signaling pathways linking guidance cues to changes in growth
cone cytoskeletal dynamics have been characterized, the aim of this dissertation is to extend our
knowledge of mechanisms controlling growth cone morphology via two main studies: (1) To
examine how PI-3K affects growth cone dynamics and the identification of its intracellular
signaling pathway, and (2) To examine how neuronal NO release can influence the physiology of
other neurons nearby, with a focus on effects of NO release on growth cone dynamics.

Molecules and Mechanisms Controlling Growth Cone Dynamics and Motility
Signaling pathways
Growth cones, defined as both sensory and motor structures, are comprised of a central
domain, composed of microtubules and organelles, and lamellipodia and filopodia, which are
composed of meshworks and bundles of F-actin filaments, respectively (Smith, 1988; Huber et
al., 2003). Filopodia continuously extend and retract to sample and respond to their environment
during their journey toward their targets, and by doing so, adjust the area they sense at any given
point in time, referred to as the “action radius”. Actin-based filopodial dynamics are critical for
correct pathfinding: elimination of actin dynamics and subsequent loss of filopodia from
embryonic grasshopper pioneer growth cones by treatment with the actin depolymerizing agent
cytochalasin leads to misguidance of pioneer neurites (Bentley and Toroian-Raymond, 1986).
Treatment of Xenopus retinal growth cone with cytochalasin induces misguidance as well (Chien
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et al., 1993). Because filopodia are necessary for correct guidance and therefore the proper
wiring of the nervous system, understanding the mechanisms controlling their dynamics is
critical. Many molecules and second messengers have been identified, but critical gaps in
signaling pathways still remain. The current work contributes to a better understanding of growth
cone morphology by studying how a molecule, PI-3K, and its downstream targets (ROCK, Akt
and MEK) regulate this process.
Calcium has been demonstrated to be critical for growth cone behavior (Kater et al.,
1988; Kater and Mills, 1991; Henley and Poo, 2004). In Helisoma growth cones, an increase in
the intracellular calcium concentration [Ca2+]i induces an increase in filopodial length (Davenport
and Kater, 1992; Rehder and Kater, 1992). An increase in filopodial length was also observed
after global and regional release of calcium, via uncaging, in growth cones (Cheng et al., 2002).
Calcium also regulates neurite outgrowth (Nishi and Berg, 1981; Mattson and Kater, 1987) and
growth cone steering (Henley and Poo, 2004). Growth cone turning induced by a directed source
of a guidance cue is mediated by a local increase in [Ca2+]i on the side stimulated by the cue
(Song and Poo, 1999; Hong et al., 2000; Henley and Poo, 2004). Downstream targets of calcium
that regulate growth cone dynamics have also been identified. The effect of an increase in [Ca2+]i
on the Helisoma B5 growth cone is mediated by calmodulin and the calcium-dependent
phosphatase, calcineurin (Cheng et al., 2002), suggesting that the phosphorylation state of the
growth cone regulates filopodial dynamics.
In vivo and in vitro studies have demonstrated that kinases and phosphatases regulate
growth cone guidance (Elkins et al., 1990; Williams et al., 1994; Callahan et al., 1995; Gallo et
al., 1997). Treatment of Helisoma B5 growth cones with the general protein kinase inhibitor
K252A and specific inhibitors of protein kinase C (PKC) result in an increase in filopodial length

128
and a decrease in filopodial number (Cheng et al., 2000). Consistent with the above evidence,
our results provide new information about another protein kinase, phosphatidylinosotol-3-kinase
(PI-3K), and its downstream targets as regulators of growth cone dynamics (Tornieri et al.,
2006). Because PKC is a downstream target of PI-3K (Krasilnikov, 2000), our finding that PI-3K
inhibition induces an increase in filopodial length confirms our previous work suggesting a role
of PKC in regulating filopodial behavior (Cheng et al., 2000). This effect of PI-3K regulating
growth cone morphology also supports previous studies demonstrating a role of PI-3K in neurite
outgrowth (Kita et al., 1998; Ditlevsen et al., 2003). In addition PI-3K has been demonstrated to
mediate ephrin A5 and slit-2 induced growth cone collapse in chick retinal ganglion cells (Wong
et al., 2004). Recently our PI-3K results were supported by a study that demonstrated that
neurotrophins regulate dendritic filopodial dynamics in mouse hippocampal cultures through PI3K (Luikart et al., 2008). In addition to providing the first demonstration of the regulation of
growth cone dynamics by PI-3K, our work also unraveled the mechanisms by which PI-3K
might regulate growth cone guidance. We have shown that PI-3K affects filopodial dynamics
through its double enzymatic activity, namely its lipid kinase and protein kinase activities. Our
finding that inhibition of Rho-activated protein kinase (ROCK) causes filopodial elongation
confirms a report on retinal ganglion neurons in which filopodial elongation was elicited by
inhibition of the ROCK effector RhoA, and ROCK itself (Gehler et al., 2004; Gehler et al.,
2004). Taken together, our work demonstrates a role for PI-3K kinase in regulating growth
cone dynamics during neuronal pathfinding via both its lipid and protein kinase activities.
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Filopodial dynamics
Filopodia are continuously going through cycles of extension and retraction. Thus,
overall filopodial elongation can be explained by changes in dynamic parameters, such as the
rate at which filopodia extend and retract, as well as the amount of time that an individual
filopodium spends extending, retracting or not moving. Our laboratory has previously
demonstrated that NO-induced filopodial elongation is achieved by increasing the rate at which
filopodia elongate and the time that individual filopodia spend extending (Van Wagenen et al.,
1999). The results of changes in filopodial dynamic parameters are supported by our findings
that the filopodial elongation observed after inhibition of PI-3K is also mediated by a
combination of an increase in the extension rate and the time that filopodia spend extending
(Chapter 2). Possible changes in cytoskeletal dynamics explaining these modifications of
filopodial dynamic parameters will be explained in detail later in the discussion. It will be of
interest in the future to investigate if these changes in filopodial dynamic parameters constitute a
general mechanism mediating growth cone filopodial extension or if they are specific to
particular signaling pathways.

Physiological effect of NO on growth cone dynamics
The gaseous messenger nitric oxide (NO) has been demonstrated to regulate different
processes in the nervous system, including development, synaptic plasticity, cell death and
neurogenesis (Ernst et al., 1999; Lipton, 1999; Contestabile and Ciani, 2004; Matarredona et al.,
2005; Bicker, 2007). The fact that NO is a gas makes it an unconventional messenger, which can
diffuse across cell membranes and affect target molecules in neighboring cells. In the nervous
system, NO is formed by the conversion of L-arginine and oxygen to L-citrulline by
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calcium/calmodulin-dependent neuronal nitric oxide synthase (nNOS) (Alderton et al., 2001).
Previous studies in B5 Helisoma neurons demonstrated that global application of NO donors
induces an increase in filopodial length and a decrease in neurite outgrowth in vitro (Van
Wagenen et al., 1999; Trimm and Rehder, 2004), suggesting a role for NO as a guidance cue
regulating neuronal pathfinding. This role of NO was further supported by a recent finding that
focal application of NO onto a single growth cone induces an increase in filopodial length locally
on the stimulated growth cone via soluble guanylyl cyclase (sGC), protein kinase G (PKG),
cyclic adenosine diphosphate ribose (cADPR) and intracellular calcium release from ryanodine
sensitive stores (Welshhans and Rehder, 2005; Welshhans and Rehder, 2007).
However, this work examines the ultimate demonstration of a role for NO in affecting
growth cone motility, by studying the effect of physiological concentrations of NO on growth
cone dynamics. Although both NO release from NO-donors and single cells induces an increase
in filopodial length, the duration of this effect differs. Global stimulation with the NO donor
SIN-1, results in a long-term stimulation and induces a rapid and transient increase in filopodial
length followed by a sustained plateau during which filopodia remain elongated over control
values (Van Wagenen et al., 1999; Van Wagenen and Rehder, 2001). Local and short term
stimulation with the NO donor NOC-7 causes a transient increase in filopodial length lasting
approximately 20 minutes (Welshhans and Rehder, 2005; Welshhans and Rehder, 2007).
Stimulation by a single cell, which continuously releases NO and results in long term
stimulation, caused filopodial elongation and filopodia remained elongated in the presence of the
stimulating cell (Tornieri and Rehder, 2007). These results suggest that the duration of the NO
stimulation influences the time filopodia remain extended. Our finding that NO release from a
single cell affects growth cone morphology of neighboring growth cones entering the “plume” of
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NO strongly confirms a paracrine role of NO in regulating growth cone dynamics (Tornieri and
Rehder, 2007). This concept of NO acting in a paracrine fashion was demonstrated during the
development of the grasshopper embryo, where NO released from epithelial cells facing the
basal lamina of the antenna regulates axonal pathfinding of antennal pioneer neurons (Seidel and
Bicker, 2000; Bicker, 2007).
The fact that NO has a very short half-life, and the finding that NO release from a single
cell affects filopodial length with the same intensity as stimulation with NO donors suggests that
low concentrations of NO can have strong physiological effects on growth cone morphology.
These strong changes in filopodial dynamics may be explained by amplification of spatial and
temporal stimulation by NO through its signaling pathway, or that the system is very sensitive to
begin with and is saturated easily. This effect of a low concentration of NO on filopodial length
is also observed when NO is temporally and spatially applied on B5 growth cones for
milliseconds with a picospitzer (Welshhans and Rehder, 2005). This strong effect on growth
cone dynamics may be explained by the fact that binding of NO to the heme group of sGC
increases its catalytic activity by a hundred fold (Bellamy et al., 2002; Russwurm and Koesling,
2004). It has been demonstrated that physiological NO concentrations in the brain are in the low
nanomolar range (Hall and Garthwaite, 2006). NO sensing electrodes and fluorescent dyes such
has DAF-2A have been used to detect NO release from tissues and cells within tissues
(Friedemann et al., 1996; Bedioui et al., 1997; Kojima et al., 1998). Recently, detection of NO
release from single neurons has been performed in the isolated CNS of Lymnaea stagnalis by
using multiple film coated electrode sensors (Patel et al., 2006). Furthermore, picomolar
concentrations of NO released from single epithelial cells and hippocampal neurons were
detected by a cell-based indicator (Sato et al., 2006). Detection and quantification of NO released
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from single B5 senders will be important to investigate in the future. Our study with the senderreceiver paradigm demonstrates that B5 neurons spontaneously produce NO and that NO has
physiological effects on neighboring growth cones up to a distance of 100 µm away from the
sender cell. This finding provides crucial physiological information to previous modeling studies
of NO release, which have demonstrated a diffusion radius of approximately 200 µm from a
point source of NO (Lancaster, 1994; Wood and Garthwaite, 1994; Lancaster, 1997). Our
finding provides the first demonstration that physiological concentrations of NO affect
filopodial dynamics and strongly suggests a role of NO as a modulator of growth cone
motility during neuronal pathfinding in vivo.

Paracrine versus autocrine role of NO
The fact that B5 neurons express both nNOS and the NO target, soluble guanylyl cyclase
(sGC) (Van Wagenen and Rehder, 2001), make them unique in that they produce NO and also
can respond to it. Therefore, we can speculate that in addition to responding to NO release from
neighboring cells during pathfinding B5 neurons may also intrinsically produce NO to regulate
aspects of their own physiology. Indeed, inhibition of endogenous NOS in B5 neurons induces a
slow-down in the rate at which neurites advance (Trimm and Rehder, 2004), suggesting that their
own source of NO is necessary for a normal outgrowth rate, and down- or up-regulation of NO
production may be an intrinsic mechanism to regulate neurite advance. In our study investigating
the effect of NO release from a single cell on growth cone dynamics, inhibition of endogenous
production of NO in B5 receivers with the specific NOS inhibitor 7-NI had no effect on
filopodial dynamics (Tornieri and Rehder, 2007). This result suggests that endogenous NO may
regulate neurite outgrowth by a mechanism independent from that regulating filopodial length.
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Because nNOS is activated by calcium/calmodulin, one possible mechanism to regulate the
amount of endogenous NO production could be through changes in the intracellular calcium
concentration, which is modulated by neuronal activity. It will be of interest in the future to
investigate if there is an interaction between endogenous and exogenous NO, with the rationale
that the amount of spontaneously produced NO may modulate the response of the cell to
exogenous NO. The fact that (1) NO signaling leads to an increase in [Ca2+]i (Van Wagenen and
Rehder, 1999), and (2) [Ca2+]i regulates neurite outgrowth based on the calcium set point
hypothesis (Kater and Mills, 1991), allows one to envision a scenario in which endogenously
produced NO helps to ‘set’ the [Ca2+]i which can be further modulated by exogenous NO to
regulate growth cone behavior and neurite outgrowth. Modulation in the [Ca2+]i has been shown
to have striking effects on growth cone behavior, such as in the case of Xenopus spinal neurons,
where changes in the amplitude of total [Ca2+]i elevation were demonstrated to convert growth
cone steering from attraction to repulsion (Zheng, 2000).

Interaction between Filopodial Length, Number and Neurite Outgrowth
Slow down and search behavior
As mentioned earlier, filopodia on growth cones are motile and sensing structures crucial
for correct neuronal pathfinding. Although many studies have established the mechanisms by
which filopodial dynamics govern growth cone behaviors, such as collapse and steering, the
relationship between filopodial length and neurite outgrowth is still poorly understood. During
their journey toward their targets and depending on their position in the environment, growth
cone morphology and neurite outgrowth vary. Growth cones tend to have an elongated shape
without any filopodia and advance at a fast rate when they grow along an already established
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path laid down by other axons; whereas when growth cones are at decision points, filopodial
length increases and the speed of neurite advance decreases (Tosney and Landmesser, 1985;
Bovolenta and Mason, 1987; Godement et al., 1994; Kuhn et al., 1995; Trimm and Rehder,
2004). The latter has been referred to as a “slow down and search” behavior (Trimm and Rehder,
2004). The benefit of this behavior for a navigating growth cone would be to enhance its sensory
ability: (i) by increasing its action radius through filopodial elongation, and (ii) by increasing the
duration of its exploration of the environment.
This slow down and search behavior was also observed following inhibition of PI-3K.
Interestingly, inhibition of either ROCK or Akt, two downstream targets of PI-3K, allowed us to
separate the slow down and search behavior into a “search” and a “slow down” component
(Tornieri et al., 2006). We can envision that during pathfinding in vivo, depending on the
signaling pathway activated by guidance cues or the intensity of the stimulation, navigating
growth cones may increase their action radius and continue to advance at the same speed
(“search”) or, alternatively, increase their action radius and decrease or stop their advance (“slow
down and search”). Because of technical issues, neurite outgrowth could not be investigated in
our study using the sender-receiver paradigm, however, a previous publication from our
laboratory demonstrated that NO induces a concomitant increase in filopodial length and a
decrease in neurite outgrowth (Trimm and Rehder, 2004). The concept that the same signaling
molecule may affect filopodial dynamics and neurite outgrowth is further supported by findings
from multiple studies demonstrating that protein kinases affect both growth cone behavior and
neurite outgrowth (Bixby, 1989; Bixby and Jhabvala, 1992; Oberstar et al., 1997; Cheng et al.,
2000)
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Calcium and growth cone dynamics
Calcium has been demonstrated to be a critical regulator of growth cone behavior, with
an increase in [Ca2+]i leading to filopodial elongation and a decrease in filopodial number (Kater
and Mills, 1991; Rehder and Kater, 1992). However, filopodial elongation induced by inhibition
of PI-3K is not mediated by an increase in [Ca2+]i, suggesting that the slow down and search
behavior can be elicited by a calcium-independent mechanism as well (Tornieri et al., 2006).
Furthermore these findings suggest that a calcium-dependent signaling event, like NO signaling,
and a calcium-independent signaling event may converge on the same target to affect actin
cytoskeleton dynamics and therefore elicit the same effect on filopodial dynamics and neurite
outgrowth. Actin binding proteins (ABPs), such as cofilin and gelsolin, are good candidates for
convergence
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phosphatidylinositolphosphates and their phosphorylation state (Schafer et al., 1996; Meberg et
al., 1998; Sun et al., 1999). The involvement of these ABPs in filopodial dynamics will be
discussed in detail later in the discussion. However we cannot exclude the alternative possibility
that the absence of measurable changes in [Ca2+]i after PI-3K inhibition could be due to a
limitation in the sensitivity of the calcium indicator dye. This explanation is in agreement with
our finding that NO release from a single cell induces filopodial elongation without measurable
changes in the [Ca2+]i, as opposed to elongation induced by NO donors. Assuming that the
concentration of NO release in the sender-receiver paradigm is much smaller than the release
from NO donors, the resulting increase in [Ca2+]i. may not to be detectable but sufficient to affect
growth cone dynamics. Interestingly, we noticed that treatments that induce filopodial elongation
without increasing the [Ca2+]i,, such as PI-3K inhibition or NO release from a single cell, do not
affect filopodial number. The same was observed in a previous study in Helisoma following
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inhibition of tyrosine kinases and PKC (Cheng et al., 2000). These results suggest that: (i)
filopodial length can be regulated independently of an elevation in [Ca2+]i or (ii) filopodial length
is more sensitive to small, possibly undetectable increases in [Ca2+]i than filopodial number. The
latter is supported by a study in Helisoma, in which a small, local increase in [Ca2+]i by uncaging
calcium resulted in filopodial elongation but had no effect on filopodial number (Cheng et al.,
2002). This study suggests that a small increase in [Ca2+]i affects filopodial length alone, and not
filopodial number.

Actin Binding Proteins and Cytoskeletal Dynamics Underlying Changes in Growth Cone
Filopodia
Filopodia are composed of bundles of F-actin and any changes in filopodial length will be
mediated by changes in F-actin dynamics. Filopodial elongation can be explained by three
mechanisms: (i) an increase in actin polymerization at the barbed end of F-actin, which is located
at the tip of filopodia, (ii) a decrease in retrograde flow of F-actin, or (iii) a combination of both.
Our finding that inhibition of actin polymerization with cytochalasin B blocked the filopodial
elongation induced by PI-3K inhibition (Tornieri et al., 2006), confirms that filopodial length is
mediated by actin dynamics, and more specifically suggests that inhibition of PI-3K increases
actin polymerization at the barbed end. Our hypothesis that filopodial elongation is mediated by
an increase in actin polymerization is further supported by a study in Helisoma, where NO
donor-induced filopodial elongation was mediated by addition of actin monomers at the barbed
end (K.Welshhans, personal communication). Because simultaneous inhibition of PI-3K and
retrograde flow had an additive effect on filopodial elongation, we cannot exclude a role of PI3K in regulating retrograde flow. However, our findings that inhibition of PI-3K does not affect
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filopodial retraction parameters (retraction being thought to be driven by retrograde flow), and
that a previous study in Helisoma demonstrated that a calcium-induced slow down in retrograde
flow is dependent on changes in actin bundle dynamics in filopodia (Welnhofer et al., 1999),
strongly exclude a mechanism involving mainly retrograde flow. The fact that NO-induced
filopodial elongation is mediated by affecting the rate at which filopodia elongate and the time
that individual filopodia spend elongating, but had no effect on retraction parameters (Van
Wagenen et al., 1999), also supports our hypothesis that a slow-down of retrograde flow is not
the main mechanism involved in filopodial elongation. To summarize, the above findings
suggest that PI-3K inhibition and application of exogenous NO induce filopodial elongation by
increasing actin polymerization at the barbed end. Actin polymerization is regulated by actin
binding proteins (ABPs), which control branching, capping and polymerization. Spatial and
temporal modification of the activity of these proteins will change the actin dynamics of the
growth cone cytoskeleton, which is necessary for correct pathfinding.
There are multiple mechanisms by which PI-3K and NO might regulate F-actin
extension. The actin binding protein, profilin, controls actin dynamics by binding and
sequestering actin monomers, leading to the inhibition of actin assembly (Stossel, 1989).
Phosphatidylinositol-phosphates, such as phosphatidylinositol-3,4-biphosphate (PIP2), have been
demonstrated to prevent binding of profilin to actin monomers (Goldschmidt-Clermont et al.,
1991; Lu et al., 1996). In addition, phosphorylation of profilin by PI-3K increases its affinity for
actin monomers (Sathish et al., 2004). Therefore, PI-3K may regulate growth cone dynamics via
profilin, with the rationale that inhibition of PI-3K increases F-actin polymerization by
preventing phosphorylation of profilin and by maintaining a high amount of PIP2. This would
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then lead to an increase in the amount of free actin monomers available for addition at the plus
end.
Another ABP, gelsolin, severs actin filaments and prevents actin polymerization onto Factin by capping its barbed ends. Gelsolin is regulated by phosphatidylinositol-4,5-biphosphate
(PIP2) which causes the dissociation of gelsolin from F-actin, and by calcium which promotes
gelsolin binding to F-actin (Schafer et al., 1996; Sun et al., 1999). It may be that PI-3K inhibition
induces actin polymerization by increasing the amount of PIP2 available, and therefore
uncapping gelsolin from barbed ends to promote actin polymerization (Fig. 5.1). Because NO
induces filopodial elongation by increasing [Ca2+]i, and calcium activates gelsolin, NO may
mediate its effect on actin polymerization through gelsolin activity. This hypothesis is supported
by the finding that gelsolin promotes actin polymerization by first severing F-actin and then
uncapping the newly generated actin filaments (Sun et al., 1999; Yin and Stull, 1999)
Finally, PI-3K and NO could also regulate actin polymerization via the actin
depolymerizing factor ADF/cofilin, which increases the rate of dissociation of actin monomers
from the pointed end of F-actin and severs F-actin (Bamburg, 1999; Chen et al., 2000; Sarmiere
and Bamburg, 2004). The ability of ADF/cofilin to bind to F-actin is inhibited by
phosphorylation on serine 3 by LIM kinase (LIMK) and by binding to phosphatidylinositolphosphates (Yonezawa et al., 1991; Agnew et al., 1995; Arber et al., 1998; Sarmiere and
Bamburg,
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calcium/calmodulin-dependent phosphatase 2B (calcineurin) and slingshot activates ADF/cofilin
(Meberg et al., 1998; Niwa et al., 2002; Sarmiere and Bamburg, 2004). PI-3K can inactivate
ADF/cofilin via its lipid kinase activity by activating ROCK, which in turn activates LIMK
(Maekawa et al., 1999). LIMK then phosphorylates and deactivates ADF/cofilin. Another
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pathway to inactivate ADF/cofilin may be through its protein kinase activity by activation of Rac
and Cdc42, which in turn activate the protein kinase (PAK), which phosphorylates LIMK
(Manser et al., 1994; Edwards et al., 1999). Taken together, inhibition of PI-3K may induce actin
polymerization by inhibition of the pathways mentioned above. This proposal is supported by a
recent study on chick retinal neurons, in which BDNF induces filopodial elongation by activation
of ADF/cofilin through inhibition of ROCK (Gehler et al., 2004). In addition to mediating
filopodial elongation induced by inhibition of PI-3K, ADF/cofilin may regulate NO-induced
filopodial elongation as well. Because NO induces an increase in [Ca2+]i and dephosphorylation
of ADF/cofilin can be caused by an increase in [Ca2+]i and the calcium/calmodulin-dependent
phosphatase, calcineurin (Meberg et al., 1998), we can envision that by increasing [Ca2+]i, NO
activates calcineurin, which dephosphorylates and activates ADF/cofilin, providing more actin
monomers available for polymerization at the barbed end of F-actin. In summary, PI-3K and
NO play an important role in regulating F-actin dynamics in growth cone filopodia during
pathfinding. ABPs such as profilin, gelsolin and cofilin are the likely points of convergence
of different signaling pathways and, therefore, modification of their activity will influence
growth cone behavior (Fig. 5.1).
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Figure 5.1: Possible PI-3K and NO signaling pathways regulating filopodial length.
Activation of PI-3K by RTK leads to activation of Cdc42, Rac and ROCK, which in turn
activates PAK and LIMK, respectively. Activation of PAK and LIMK, in turn, lead to the
phosphorylation and subsequent inactivation of ADF/cofilin. PIP2 and PIP3, produced by PI-3K,
inactivate capping proteins such as gelsolin and the actin monomer sequestering protein profilin.
The activity of profilin can be enhanced via phosphorylation by PI-3K. An increase in [Ca2+]i by
endogenous and exogenous NO activates calcineurin, which in turn dephosphorylates and
activates ADF/cofilin. [Ca2+]i also activates gelsolin.
PI-3K: phosphatidylinositol-3 kinase; RTK: receptor tyrosine kinase; ROCK: RhoA activated
protein kinase; PIP2: phosphatidylinositol-biphosphates; PIP3: phosphatidylinositoltriphosphates; LIMK: LIM kinase; [Ca2+]i: intracellular calcium concentration; ADF: actin
depolymerizing factor.
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Conclusions
Taken together, the studies presented in this dissertation provide new insights into the
signaling mechanisms that control growth cone dynamics.

In Specific Aim 1 (Chapter 2), we demonstrated a role of PI-3K in regulating growth
cone dynamics and motility. Inhibition of PI-3K induces both an increase in filopodial length and
a decrease in the rate of neurite outgrowth. These effects were mediated by the lipid and protein
kinase activities of PI-3K, resulting in the activation of Akt, ROCK and MEKK respectively.
Filopodial elongation induced by inhibition of PI-3K is mediated by an increase in the time
individual filopodia spend extending and by an increase in the rate at which filopodia extend. We
also have demonstrated that filopodial elongation resulting from the inhibition of PI-3K is
mediated by an increase in actin polymerization at the barbed end. Therefore, these results
demonstrate that PI-3K and its downstream targets can regulate growth cone dynamics, which
are known to be crucial for correct neuronal pathfinding in vivo.

In Specific Aim 2 (Chapter 3), we have shown that physiological concentrations of NO
can affect growth cone dynamics. NO release from a single cell induces a rapid increase in
filopodial length. This effect on filopodial dynamics is reversible, mediated by the canonical
target of NO, sGC, and limited to the stimulated growth cone. Cellular NO can have a
physiological effect on filopodial dynamics at a distance of up to 100 µm. Therefore, these
results demonstrate that physiological release of NO can affect growth cone morphology.
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The proper functioning of the nervous system depends on the formation of correct
connectivity during development. Misguidance or failure to wire correctly can lead to clinical
disorders often related to cognitive and mental illness, or to neuromuscular dysfunction, which
occurs in spinal muscular atrophy. A combination of clinical and cell culture studies have started
to describe the molecules and mechanisms underlying these diseases. In vitro studies often allow a
deeper understanding into the molecular and cellular mechanisms regulating many processes of
neuronal development, such as neuronal survival, differentiation, motility, pathfinding and
synaptogenesis, because they simplify the complexities that occur when studying these events in
vivo. Our findings on how NO and PI-3K affect filopodial dynamics provide novel insight into the
cellular mechanisms controlling growth cone motility in vitro, which is known to be critical for
correct pathfinding and establishment of appropriate connectivity. Studies focusing on single
molecules provide critical information on signaling pathways, but in vivo, multiple molecules and
their signals interact with each other to govern a specific growth cone behavior. Therefore in the
future, to better understand growth cone behavior in vivo, studies will need to focus on how growth
cones integrate different signals, and on mechanisms involved in modulating growth cone
responses to specific guidance cues. Follow up studies to the in vitro assay used here will need to
test the role of identified molecules and second messengers affecting growth cone dynamics in
vivo. This will allow for an understanding of their role in the development of the nervous system.
In conclusion, these studies not only provide new information about signaling pathways
and second messengers regulating growth cone dynamics, but also contribute to our
understanding of the mechanistic basis of wiring defects associated with brain abnormalities.
Most importantly, a better understanding of the cellular and molecular mechanisms regulating
growth cone motility during the development of the nervous system may provide the foundation
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for clinical approaches to enhance correct navigation and appropriate connectivity of neuronal
circuitry to promote regeneration and repair following nerve injury and degeneration.
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